[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_83289c5a-0e1a-4089-90d0-8447ef02c8ba":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:83289c5a-0e1a-4089-90d0-8447ef02c8ba,\"}":671},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":660,"relativeEntities":661,"slug":662,"properties":663,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":668,"manageAffiliations":669,"indexDatabases":670,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},"83289c5a-0e1a-4089-90d0-8447ef02c8ba","2023-12-05T06:03:54.978+00:00",[],"EMC-Ginecolog%C3%ADa-Obstetricia",{"issn":664,"title":666},{"VOID":665},"1283081X",{"EN":667},"EMC - Ginecología-Obstetricia",[],[],[],{"meta":672,"data":674},{"total":673},"233",[675,773,832,934,967,1035,1312,1386,1446,1538],{"id":676,"createTime":677,"updateTime":678,"relativeEntities":679,"slug":680,"properties":681,"entityType":688,"verifyStatus":25,"verifyTime":689,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":691,"fullTextUrl":26,"authors":692,"publicationType":747,"publisherRelationship":748,"citationCount":36,"citationInfo":762,"publishDate":764,"publishYear":765,"citationAnalyzeStatus":766,"lastCitationAnalyze":767,"indexDatabases":26,"openAccess":26,"references":768,"isForceReanalyzing":772},"2e0022d8-691d-47c1-805b-2646aae83a4e","2024-01-24T08:55:54.986+00:00","2026-06-10T12:40:31.574+00:00",[],"Tratamiento-de-la-f%C3%ADstula-rectovaginal-y-de-las-secuelas-obst%C3%A9tricas",{"title":682,"doi":684,"gsPaper":686},{"ES":683},"Tratamiento de la fístula rectovaginal y de las secuelas obstétricas",{"VOID":685},"10.1016\u002Fs1283-081x(20)43720-8",{"VOID":687},"[\"8941905162942479020\"]","PUBLICATION","2024-05-03T00:37:56.136+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X20437208",[693,709,721,733],{"id":694,"sortIndex":59,"researcher":26,"roles":695,"affiliations":697,"properties":706},"39888c05-cf30-4eaf-ab45-faf3ce88e0b8",[696],"AUTHOR",[698],{"id":26,"sortIndex":36,"affiliation":699,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":702,"slug":26,"properties":703,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d4d18b5e-933d-4c7a-8252-f956d23d19a2","2024-01-24T08:55:55.012+00:00",[],{"title":704},{"VI":705},"Service de chirurgie gynécologique, Hôpital Jeanne-de-Flandre, CHU de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France",{"title":707},{"VI":708},"S. Delplanque",{"id":710,"sortIndex":114,"researcher":26,"roles":711,"affiliations":712,"properties":718},"a42857fa-931d-4443-b6a7-eeb4d3d287d4",[696],[713],{"id":26,"sortIndex":36,"affiliation":714,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":715,"slug":26,"properties":716,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":717},{"VI":705},{"title":719},{"VI":720},"E. Declas",{"id":722,"sortIndex":115,"researcher":26,"roles":723,"affiliations":724,"properties":730},"cf770415-864d-4750-a611-abe739471221",[696],[725],{"id":26,"sortIndex":36,"affiliation":726,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":727,"slug":26,"properties":728,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":729},{"VI":705},{"title":731},{"VI":732},"G. Giraudet",{"id":734,"sortIndex":36,"researcher":26,"roles":735,"affiliations":736,"properties":742},"08fc2047-379d-421d-a1db-869f3b3936fd",[696],[737],{"id":26,"sortIndex":36,"affiliation":738,"properties":26},{"id":700,"createTime":701,"updateTime":701,"relativeEntities":739,"slug":26,"properties":740,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":741},{"VI":705},{"title":743,"gsAuthor":745},{"VI":744},"M. Cosson",{"VOID":746},"[\"mra9H5MAAAAJ\"]","ARTICLE",{"url":691,"publisher":749,"properties":757},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":750,"slug":662,"properties":751,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":754,"manageAffiliations":755,"indexDatabases":756,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":752,"title":753},{"VOID":665},{"EN":667},[],[],[],{"volume":758,"pages":760},{"VOID":759},"56",{"VOID":761},"1-12",{"total":36,"publishYear":36,"statisticByYear":763},{},"2020-05-01",2020,"ERROR_IN_ANALYZE_CITATION","2026-06-10T12:40:31.573+00:00",[769],{"id":26,"text":770,"url":26,"identifiers":771},"Cosson, 2011",{},false,{"id":774,"createTime":775,"updateTime":776,"relativeEntities":777,"slug":778,"properties":779,"entityType":688,"verifyStatus":25,"verifyTime":786,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":787,"fullTextUrl":26,"authors":788,"publicationType":747,"publisherRelationship":816,"citationCount":26,"citationInfo":26,"publishDate":830,"publishYear":831,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"38efd8f4-8f94-4a9a-aab4-98037fde0cd2","2024-01-26T07:49:12.003+00:00","2025-02-09T14:37:55.955+00:00",[],"Recidivas-locorregionales-del-c%C3%A1ncer-de-mama",{"references":780,"title":782,"doi":784},{"VOID":781},"Site de l’institut national du cancer ; (http :\u002F\u002Flesdonnees.e-cancer.fr).\nAndry, 1989, Locoregional recurrences after 649 modified radical mastectomies : incidence and significance, Eur J Surg Oncol, 15, 476\nArriagada, 2002, Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer, Ann Oncol, 13, 1404, 10.1093\u002Fannonc\u002Fmdf227\nSchmoor, 2000, Role of isolated locoregional recurrence of breast cancer : results of four prospective studies, J Clin Oncol, 18, 1696, 10.1200\u002FJCO.2000.18.8.1696\nClemons, 2001, Locoregionally recurrent breast cancer : incidence, risk factors and survival, Cancer Treat Rev, 27, 67, 10.1053\u002Fctrv.2000.0204\nAnderson, 2009, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer, J Clin Oncol, 27, 2466, 10.1200\u002FJCO.2008.19.8424\nWapnir, 2006, Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials, J Clin Oncol, 24, 2028, 10.1200\u002FJCO.2005.04.3273\nFortin, 1999, Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy, J Clin Oncol, 17, 101, 10.1200\u002FJCO.1999.17.1.101\nTaghian, 2004, J Clin Oncol, 22, 4247, 10.1200\u002FJCO.2004.01.042\nFisher, 1991, Significance of ipsilateral breast tumour recurrence after lumpectomy, Lancet, 338, 327, 10.1016\u002F0140-6736(91)90475-5\nFisher, 1992, Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation : pathological findings from NSABP protocol B-06, Semin Surg Oncol, 8, 161\nVeronesi, 1995, Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events, J Natl Cancer Inst, 87, 19, 10.1093\u002Fjnci\u002F87.1.19\nFisher, 2002, Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer, N Engl J Med, 347, 1233, 10.1056\u002FNEJMoa022152\nLe, 2002, Prognostic factors for death after an isolated local recurrence in patients with early-stage breast carcinoma, Cancer, 94, 2813, 10.1002\u002Fcncr.10572\nGalper, 2005, Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer, Int J Radiat Oncol Biol Phys, 61, 348, 10.1016\u002Fj.ijrobp.2004.06.011\nSalvadori, 1999, Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery, Br J Surg, 86, 84, 10.1046\u002Fj.1365-2168.1999.00961.x\nClarke, 2005, Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials, Lancet, 366, 2087, 10.1016\u002FS0140-6736(05)67887-7\nVeronesi, 2002, Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer, N Engl J Med, 347, 1227, 10.1056\u002FNEJMoa020989\nJacobson, 1995, Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer, N Engl J Med, 332, 907, 10.1056\u002FNEJM199504063321402\nvan Dongen, 2000, Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial, J Natl Cancer Inst, 92, 1143, 10.1093\u002Fjnci\u002F92.14.1143\nSarrazin, 1989, Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer, Radiother Oncol, 14, 177, 10.1016\u002F0167-8140(89)90165-5\nBlichert-Toft, 1992, Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis, J Natl Cancer Inst Monogr, 19\nHuang, 2002, Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences, Cancer, 95, 2059, 10.1002\u002Fcncr.10952\nKomoike, 2005, Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors, Breast Cancer, 12, 104, 10.2325\u002Fjbcs.12.104\nYoshida, 2010, True recurrences and new primary tumors have different clinical features in invasive breast cancer patients with ipsilateral breast tumor relapse after breast-conserving treatment, Breast J, 16, 127, 10.1111\u002Fj.1524-4741.2009.00884.x\nPanet-Raymond, 2011, True recurrence versus new primary: an analysis of ipsilateral breast tumor recurrences after breast-conserving therapy, Int J Radiat Oncol Biol Phys, 81, 409, 10.1016\u002Fj.ijrobp.2010.05.063\nYi, 2011, Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning, Ann Surg, 253, 572, 10.1097\u002FSLA.0b013e318208fc2a\nBollet, 2008, High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers, J Natl Cancer Inst, 100, 48, 10.1093\u002Fjnci\u002Fdjm266\nVicini, 2007, The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy, Cancer, 109, 1264, 10.1002\u002Fcncr.22529\nSmith, 2000, True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management, Int J Radiat Oncol Biol Phys, 48, 1281, 10.1016\u002FS0360-3016(00)01378-X\nWoodward, 2010, Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival, Breast Cancer Res Treat, 123, 597, 10.1007\u002Fs10549-010-0829-8\nBuchanan, 2006, Locoregional recurrence after mastectomy: incidence and outcomes, J Am Coll Surg, 203, 469, 10.1016\u002Fj.jamcollsurg.2006.06.015\nHarris, 2003, Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy, Cancer, 98, 2144, 10.1002\u002Fcncr.11767\nReddy, 2010, Long-term outcomes in patients with isolated supraclavicular nodal recurrence after mastectomy and doxorubicin-based chemotherapy for breast cancer, Int J Radiat Oncol Biol Phys, 80, 1453, 10.1016\u002Fj.ijrobp.2010.04.015\nJaffre, 2009, Prognosis for isolated skin recurrence after breast cancer treated by mastectomy, Anticancer Res, 29, 1697\nBurstein, 2004, Ductal carcinoma in situ of the breast, N Engl J Med, 350, 1430, 10.1056\u002FNEJMra031301\nBoyages, 1999, Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis, Cancer, 85, 616, 10.1002\u002F(SICI)1097-0142(19990201)85:3\u003C616::AID-CNCR12>3.0.CO;2-7\nWapnir, 2011, Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS, J Natl Cancer Inst, 103, 478, 10.1093\u002Fjnci\u002Fdjr027\nFisher, 2001, Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience, Semin Oncol, 28, 400, 10.1016\u002FS0093-7754(01)90133-2\nBijker, 2006, J Clin Oncol, 24, 3381, 10.1200\u002FJCO.2006.06.1366\nHolmberg, 2008, Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast, J Clin Oncol, 26, 1247, 10.1200\u002FJCO.2007.12.7969\nHoughton, 2003, Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial, Lancet, 362, 95, 10.1016\u002FS0140-6736(03)13859-7\nViani, 2007, Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials, Radiat Oncol, 2, 28, 10.1186\u002F1748-717X-2-28\nSilverstein, 1999, The influence of margin width on local control of ductal carcinoma in situ of the breast, N Engl J Med, 340, 1455, 10.1056\u002FNEJM199905133401902\nSilverstein, 1996, A prognostic index for ductal carcinoma in situ of the breast, Cancer, 77, 2267, 10.1002\u002F(SICI)1097-0142(19960601)77:11\u003C2267::AID-CNCR13>3.0.CO;2-V\nWong, 2006, Prospective study of wide excision alone for ductal carcinoma in situ of the breast, J Clin Oncol, 24, 1031, 10.1200\u002FJCO.2005.02.9975\nHughes, 2009, Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group, J Clin Oncol, 27, 5319, 10.1200\u002FJCO.2009.21.8560\nMotwani, 2011, Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194, Cancer, 117, 1156, 10.1002\u002Fcncr.25623\nKrag, 2007, Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial, Lancet Oncol, 8, 881, 10.1016\u002FS1470-2045(07)70278-4\nVeronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N Engl J Med, 349, 546, 10.1056\u002FNEJMoa012782\nNaik, 2004, The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures, Ann Surg, 240, 462, 10.1097\u002F01.sla.0000137130.23530.19\nvan der Ploeg, 2008, Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature, Eur J Surg Oncol, 34, 1277, 10.1016\u002Fj.ejso.2008.01.034\nKrag, 2010, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, 11, 927, 10.1016\u002FS1470-2045(10)70207-2\nDel Bianco, 2008, Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial, Eur J Surg Oncol, 34, 508, 10.1016\u002Fj.ejso.2007.05.017\nFisher, 1981, The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast, Surg Gynecol Obstet, 152, 765\nGoyal, 2004, Predictors of non-sentinel lymph node metastasis in breast cancer patients, Eur J Cancer, 40, 1731, 10.1016\u002Fj.ejca.2004.04.006\nHwang, 2003, Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer, Ann Surg Oncol, 10, 248, 10.1245\u002FASO.2003.05.020\nNos, 2003, Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases, Br J Surg, 90, 1354, 10.1002\u002Fbjs.4325\nAlran, 2007, Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy, Ann Surg Oncol, 14, 2195, 10.1245\u002Fs10434-006-9331-2\nHouvenaeghel, 2009, A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis, Eur J Surg Oncol, 35, 690, 10.1016\u002Fj.ejso.2008.10.003\nVan Zee, 2003, A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy, Ann Surg Oncol, 10, 1140, 10.1245\u002FASO.2003.03.015\nCoutant, 2009, Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study, Breast Cancer Res Treat, 113, 537, 10.1007\u002Fs10549-008-9967-7\nPark, 2007, A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram, Ann Surg, 245, 462, 10.1097\u002F01.sla.0000250439.86020.85\nGrube, 2001, Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial, Semin Surg Oncol, 20, 230, 10.1002\u002Fssu.1038\nGiuliano, 2011, Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, 305, 569, 10.1001\u002Fjama.2011.90\nBeadle, 2009, Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach, Int J Radiat Oncol Biol Phys, 73, 734, 10.1016\u002Fj.ijrobp.2008.04.078\nTruong, 2009, Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy, Int J Radiat Oncol Biol Phys, 73, 357, 10.1016\u002Fj.ijrobp.2008.04.034\nVoogd, 2001, Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials, J Clin Oncol, 19, 1688, 10.1200\u002FJCO.2001.19.6.1688\nGentilini, 2007, When can a second conservative approach be considered for ipsilateral breast tumour recurrence?, Ann Oncol, 18, 468, 10.1093\u002Fannonc\u002Fmdl424\nOh, 2006, The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: how young is “young”?, Int J Radiat Oncol Biol Phys, 65, 1345, 10.1016\u002Fj.ijrobp.2006.03.028\nGarg, 2007, Effect of postmastectomy radiotherapy in patients \u003C 35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy, Int J Radiat Oncol Biol Phys, 69, 1478, 10.1016\u002Fj.ijrobp.2007.05.029\nPark, 2009, High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer, Int J Radiat Oncol Biol Phys, 73, 75, 10.1016\u002Fj.ijrobp.2008.04.007\nEwertz, 2011, Effect of obesity on prognosis after early-stage breast cancer, J Clin Oncol, 29, 25, 10.1200\u002FJCO.2010.29.7614\nGabos, 2010, The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer, Breast Cancer Res Treat, 124, 187, 10.1007\u002Fs10549-010-1135-1\nLi, 2011, Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 chinese breast cancer cases, Ann Surg Oncol, 18, 2492, 10.1245\u002Fs10434-011-1626-2\nSinn, 1998, Extensive and predominant in situ component in breast carcinoma: their influence on treatment results after breast-conserving therapy, Eur J Cancer, 34, 646, 10.1016\u002FS0959-8049(97)10106-X\nHolland, 1990, The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast, J Clin Oncol, 8, 113, 10.1200\u002FJCO.1990.8.1.113\nAlbert, 2010, Estrogen\u002Fprogesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a, bN0 breast cancer, Int J Radiat Oncol Biol Phys, 77, 1296, 10.1016\u002Fj.ijrobp.2009.12.011\nPanoff, 2011, Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation, Breast Cancer Res Treat, 128, 899, 10.1007\u002Fs10549-011-1495-1\nMeyers, 2011, Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer, Ann Surg Oncol, 18, 2851, 10.1245\u002Fs10434-011-1665-8\nMontagna, 2012, Breast cancer subtypes and outcome after local and regional relapse, Ann Oncol, 23, 324, 10.1093\u002Fannonc\u002Fmdr129\nFreedman, 2009, Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation, Cancer, 115, 946, 10.1002\u002Fcncr.24094\nVoduc, 2010, Breast cancer subtypes and the risk of local and regional relapse, J Clin Oncol, 28, 1684, 10.1200\u002FJCO.2009.24.9284\nAlbert, 2011, Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer, Cancer, 117, 1595, 10.1002\u002Fcncr.25694\nWang, 2010, Triple-negative or HER2-positive status predicts higher rates of locoregional recurrence in node-positive breast cancer patients after mastectomy, Int J Radiat Oncol Biol Phys, 80, 1095, 10.1016\u002Fj.ijrobp.2010.03.038\nKwan, 2010, Does HER2 status influence locoregional failure rates in breast cancer patients treated with mastectomy for pT1-2pN0 disease?, Ann Oncol, 21, 988, 10.1093\u002Fannonc\u002Fmdp396\nBidard, 2009, Disseminated tumor cells and the risk of locoregional recurrence in nonmetastatic breast cancer, Ann Oncol, 20, 1836, 10.1093\u002Fannonc\u002Fmdp200\nHoussami, 2010, Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy, Eur J Cancer, 46, 3219, 10.1016\u002Fj.ejca.2010.07.043\nCuzick, 2011, Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\u002FANZ DCIS trial, Lancet Oncol, 12, 21, 10.1016\u002FS1470-2045(10)70266-7\nPetrelli, 2011, Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials, Radiother Oncol, 100, 195, 10.1016\u002Fj.radonc.2011.02.005\nMauri, 2005, Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis, J Natl Cancer Inst, 97, 188, 10.1093\u002Fjnci\u002Fdji021\nBuzdar, 2005, Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer, J Clin Oncol, 23, 3676, 10.1200\u002FJCO.2005.07.032\nLiedtke, 2008, Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer, J Clin Oncol, 26, 1275, 10.1200\u002FJCO.2007.14.4147\nChen, 2004, Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience, J Clin Oncol, 22, 2303, 10.1200\u002FJCO.2004.09.062\nAlpert, 2005, Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation, Int J Radiat Oncol Biol Phys, 63, 845, 10.1016\u002Fj.ijrobp.2005.02.035\nSchnitt, 1985, Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance, Int J Radiat Oncol Biol Phys, 11, 1277, 10.1016\u002F0360-3016(85)90242-1\nKurtz, 1991, Is breast conservation after local recurrence feasible?, Eur J Cancer, 27, 240, 10.1016\u002F0277-5379(91)90505-8\nVoogd, 1999, Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer, Eur J Cancer, 35, 1828, 10.1016\u002FS0959-8049(99)00220-8\nKomoike, 2003, Repeat lumpectomy for patients with ipsilateral breast tumor recurrence after breast-conserving surgery. Preliminary results, Oncology, 64, 1, 10.1159\u002F000066512\nKuerer, 2004, Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation, Cancer, 100, 2269, 10.1002\u002Fcncr.20257\nDeutsch, 2002, Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation, Int J Radiat Oncol Biol Phys, 53, 687, 10.1016\u002FS0360-3016(02)02785-2\nTrombetta, 2008, Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience, Brachytherapy, 7, 29, 10.1016\u002Fj.brachy.2007.12.001\nChadha, 2008, The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer, Brachytherapy, 7, 22, 10.1016\u002Fj.brachy.2007.10.006\nResch, 2002, Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy–a second chance to preserve the breast, Radiology, 225, 713, 10.1148\u002Fradiol.2253011913\nHannoun-Levi, 2004, Partial breast irradiation as second conservative treatment for local breast cancer recurrence, Int J Radiat Oncol Biol Phys, 60, 1385, 10.1016\u002Fj.ijrobp.2004.05.035\nKuo, 2008, Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence, Int J Radiat Oncol Biol Phys, 72, 1456, 10.1016\u002Fj.ijrobp.2008.03.042\nBeck, 1983, Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients, J Clin Oncol, 1, 400, 10.1200\u002FJCO.1983.1.6.400\nHalverson, 1992, Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy, Am J Clin Oncol, 15, 93, 10.1097\u002F00000421-199204000-00001\nJanjan, 1986, Management of locoregional recurrent breast cancer, Cancer, 58, 1552, 10.1002\u002F1097-0142(19861001)58:7\u003C1552::AID-CNCR2820580728>3.0.CO;2-W\nWaeber, 2003, Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23\u002F82) comparing tamoxifen with observation, Ann Oncol, 14, 1215, 10.1093\u002Fannonc\u002Fmdg347\nBorner, 1994, First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation, J Clin Oncol, 12, 2071, 10.1200\u002FJCO.1994.12.10.2071\nRauschecker H, Clarke M, Gatzemeier W, Recht A. Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev 2001;(4):CD002195.\nWapnir, 2008, Progress on BIG 1-02\u002FIBCSG 27-02\u002FNSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer, Ann Surg Oncol, 15, 3227, 10.1245\u002Fs10434-008-0129-2",{"ES":783},"Recidivas locorregionales del cáncer de mama",{"VOID":785},"10.1016\u002Fs1283-081x(14)66862-4","2025-02-09T14:37:55.954+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X14668624",[789,804],{"id":790,"sortIndex":36,"researcher":26,"roles":791,"affiliations":792,"properties":801},"bedba40a-3979-43ad-b0cf-3b4f60d1975c",[696],[793],{"id":26,"sortIndex":36,"affiliation":794,"properties":26},{"id":795,"createTime":796,"updateTime":796,"relativeEntities":797,"slug":26,"properties":798,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1af7c9b7-d117-4930-b430-407dadbf1572","2024-01-26T07:49:12.027+00:00",[],{"title":799},{"VI":800},"Chirurgie oncologique et reconstructrice, ICM Val d’Aurelle, 34298 Montpellier, France",{"title":802},{"VI":803},"P.-E. Colombo",{"id":805,"sortIndex":115,"researcher":26,"roles":806,"affiliations":807,"properties":813},"56342c95-1400-492a-b5f4-6dd7db30b676",[696],[808],{"id":26,"sortIndex":36,"affiliation":809,"properties":26},{"id":795,"createTime":796,"updateTime":796,"relativeEntities":810,"slug":26,"properties":811,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":812},{"VI":800},{"title":814},{"VI":815},"P. Rouanet",{"url":787,"publisher":817,"properties":825},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":818,"slug":662,"properties":819,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":822,"manageAffiliations":823,"indexDatabases":824,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":820,"title":821},{"VOID":665},{"EN":667},[],[],[],{"volume":826,"pages":828},{"VOID":827},"50",{"VOID":829},"1-16","2014-03-01",2014,{"id":833,"createTime":834,"updateTime":835,"relativeEntities":836,"slug":837,"properties":838,"entityType":688,"verifyStatus":25,"verifyTime":835,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":115,"primaryUrl":845,"fullTextUrl":26,"authors":846,"publicationType":747,"publisherRelationship":918,"citationCount":26,"citationInfo":26,"publishDate":932,"publishYear":933,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"026c9691-1dae-44b9-a2f8-c55c97b73d3f","2024-02-13T14:54:18.979+00:00","2025-01-27T08:28:40.330+00:00",[],"Histeroscopia-quir%C3%BArgica",{"references":839,"title":841,"doi":843},{"VOID":840},"Neveu, 2017, Standardizing hysteroscopy teaching: development of a curriculum using the Delphi method, Surg Endosc, 31, 5389, 10.1007\u002Fs00464-017-5620-z\nLopes, 2017, An overview of the results of hysterosonography prior to in vitro fertilization, JBRA Assist Reprod, 21, 302\nBouzid, 2016, Feasibility and diagnostic value of hysterosonography performed in bleeding time in the exploration of abnormal uterine bleeding, J Gynecol Obstet Biol Reprod, 45, 1067, 10.1016\u002Fj.jgyn.2016.03.008\nde Kroon, 2003, Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis, Int J Obstet Gynaecol, 110, 938, 10.1111\u002Fj.1471-0528.2003.02472.x\nDudiak, 2001, Hysterosonography: a key to what is inside the uterus, Ultrasound Q, 17, 73, 10.1097\u002F00013644-200106000-00002\nDeffieux, 2013, Prevention of the complications related to hysteroscopy: guidelines for clinical practice, J Gynecol Obstet Biol Reprod, 42, 1032, 10.1016\u002Fj.jgyn.2013.09.008\nDreisler, 2019, Asherman's syndrome: current perspectives on diagnosis and management, Int J Womens Health, 11, 191, 10.2147\u002FIJWH.S165474\nSalle, 1999, Transvaginal sonohysterographic evaluation of intrauterine adhesions, J Clin Ultrasound, 27, 131, 10.1002\u002F(SICI)1097-0096(199903\u002F04)27:3\u003C131::AID-JCU5>3.0.CO;2-3\nSoares, 2000, Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases, Fertil Steril, 73, 406, 10.1016\u002FS0015-0282(99)00532-4\nBerridge, 2004, Saline infusion sonohysterography: technique, indications, and imaging findings, J Ultrasound Med, 23, 97, 10.7863\u002Fjum.2004.23.1.97\nSabry, 2018, Diagnostic value of three-dimensional saline infusion sonohysterography in the evaluation of the uterus and uterine cavity lesions, Pol J Radiol, 83, e482, 10.5114\u002Fpjr.2018.80132\nWamsteker, 1988, Diagnostic and therapeutic applications of hysteroscopy, Ned Tijdschr Geneeskd, 132, 2041\nCapella-Allouc, 1999, Hysteroscopic treatment of severe Asherman's syndrome and subsequent fertility, Hum Reprod, 14, 1230, 10.1093\u002Fhumrep\u002F14.5.1230\nFernandez, 2012, Total adhesions treated by hysteroscopy: must we stop at two procedures?, Fertil Steril, 98, 980, 10.1016\u002Fj.fertnstert.2012.06.032\nThubert, 2015, Influence of auto-cross-linked hyaluronic acid gel on pregnancy rate and hysteroscopic outcomes following surgical removal of intra-uterine adhesions, Eur J Obstet Gynecol Reprod Biol, 193, 65, 10.1016\u002Fj.ejogrb.2015.06.025\nWarembourg, 2015, Prevention and treatment of intra-uterine synechiae: review of the literature, J Gynecol Obstet Biol Reprod, 44, 366, 10.1016\u002Fj.jgyn.2014.10.014\nZhang, 2018, Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase, Stem Cell Res Ther, 9, 36, 10.1186\u002Fs13287-018-0777-5\nFernandez, 2012, Post-curettage and aspiration synechiae: is there value in an anti-adhesion agent?, J Gynecol Obstet Biol Reprod, 41, H8, 10.1016\u002FS0368-2315(12)70004-2\nGrimbizis, 2013, The ESHRE-ESGE consensus on the classification of female genital tract congenital anomalies, Gynecol Surg, 10, 199, 10.1007\u002Fs10397-013-0800-x\nRikken, 2018, The randomised uterine septum transsection trial (TRUST): design and protocol, BMC Womens Health, 18, 1, 10.1186\u002Fs12905-018-0637-6\nGarbin, 1997, Transcervical hysteroplasty: indications, techniques and results. 125 cases, Contracept Fertil Sex, 25, 843\nNagel, 1993, Hysteroscopic metroplasty in the diethylstilbestrol-exposed uterus and similar nonfusion anomalies: effects on subsequent reproductive performance; a preliminary report, Fertil Steril, 59, 502, 10.1016\u002FS0015-0282(16)55789-6\nFernandez, 2011, Surgical approach to and reproductive outcome after surgical correction of a T-shaped uterus, Hum Reprod, 26, 1730, 10.1093\u002Fhumrep\u002Fder056\nGarbin, 1998, Hysteroscopic metroplasty in diethylstilboestrol-exposed and hypoplastic uterus: a report on 24 cases, Hum Reprod, 13, 2751, 10.1093\u002Fhumrep\u002F13.10.2751\nMcIlwaine, 2015, A prospective study of the use of the Myosure resectoscope to manage endometrial polyps in an outpatient setting, Aust N Z J Obstet Gynaecol, 55, 482, 10.1111\u002Fajo.12382\nNoventa, 2015, Intrauterine morcellator devices: the icon of hysteroscopic future or merely a marketing image? A systematic review regarding safety, efficacy, advantages, and contraindications, Reprod Sci, 22, 1289, 10.1177\u002F1933719115578929\nScheiber, 2016, A prospective multicenter registry of patients undergoing hysteroscopic morcellation of uterine polyps and myomas, J Gynecol Surg, 32, 318, 10.1089\u002Fgyn.2016.0008\nRodriguez, 2019, Endometrial resection and ablation techniques for heavy menstrual bleeding, Cochrane Database Syst Rev\nKalampokas, 2018, Endometrial cancer after endometrial ablation or resection for menorrhagia, Int J Gynaecol Obstet, 142, 84, 10.1002\u002Fijgo.12503\nPhilip, 2018, Evaluation of NovaSure® global endometrial ablation in symptomatic adenomyosis: a longitudinal study with a 36 month-follow-up, Eur J Obstet Gynecol Reprod Biol, 227, 46, 10.1016\u002Fj.ejogrb.2018.04.001\nLou, 2019, The second generation endometrial ablation (NovaSure) improves efficacy of levonorgestrel-releasing intrauterine system in management of adenomyosis, Zhejiang Univ Med Sci, 48, 136\nThiel, 2014, Evaluation of the Novasure endometrial ablation procedure in women with uterine cavity length over 10cm, J Obstet Gynaecol Can, 36, 491, 10.1016\u002FS1701-2163(15)30562-4\nCooper, 2019, Laparoscopic supracervical hysterectomy versus endometrial ablation for women with heavy menstrual bleeding (HEALTH): a parallel-group, open-label, randomised controlled trial, Lancet, 394, 1425, 10.1016\u002FS0140-6736(19)31790-8\nFlorio, 2012, Hysteroscopic treatment of the cesarean-induced isthmocele in restoring infertility, Curr Opin Obstet Gynecol, 24, 180, 10.1097\u002FGCO.0b013e3283521202\nCalzolari, 2019, Prevalence of infertility among patients with isthmocele and fertility outcome after isthmocele surgical treatment: a retrospective study, Ochsner J, 19, 204, 10.31486\u002Ftoj.18.0048\nMunro, 2011, The flexible FIGO classification concept for underlying causes of abnormal uterine bleeding, Semin Reprod Med, 29, 391, 10.1055\u002Fs-0031-1287663\nBettocchi, 2009, A new hysteroscopic technique for the preparation of partially intramural myomas in office setting (OPPIuM technique): a pilot study, J Minim Invasive Gynecol, 16, 748, 10.1016\u002Fj.jmig.2009.07.016\nFernandez, 2011, Update on the management of menometrorrhagia: new surgical approaches, Gynecol Endocrinol, 27, 1131, 10.3109\u002F09513590.2011.634261\nDi SpiezioSardo, 2017, The role of hysteroscopy in the diagnosis and treatment of adenomyosis, BioMed Res Int, 2017, e2518396, 10.1155\u002F2017\u002F2518396\nGeorgiou, 2018, Hysteroscopic tissue removal system (MyoSure) for the resection of polyps, sub-mucosal leiomyomas and retained products of conception in an out-patient setting: a single UK institution experience, Eur J Obstet Gynecol Reprod Biol, 231, 147, 10.1016\u002Fj.ejogrb.2018.10.030\nFaivre, 2009, Hysteroscopic management of residual trophoblastic tissue and reproductive outcome: a pilot study, J Minim Invasive Gynecol, 16, 487, 10.1016\u002Fj.jmig.2009.04.011\nRein, 2011, Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage, J Minim Invasive Gynecol, 18, 774, 10.1016\u002Fj.jmig.2011.08.003\nGulec, 2010, Osseous metaplasia of the endometrium, BMJ Case Rep, 2010, 10.1136\u002Fbcr.04.2010.2931\nGrigore, 2018, Ultrasound features of osseous metaplasia of the endometrium – Case series and review of the literature, Clin Imaging, 52, 260, 10.1016\u002Fj.clinimag.2018.08.006\nMadaan, 2015, Osseous metaplasia of the endometrium and successful hysteroscopic resection: a report of two cases and a review of the literature, Asian J Endosc Surg, 8, 63, 10.1111\u002Fases.12153\nCarin, 2015, Intra uterine devices removal during office hysteroscopy: about 36 cases, J Gynecol Obstet Biol Reprod, 44, 653, 10.1016\u002Fj.jgyn.2014.09.005",{"ES":842},"Histeroscopia quirúrgica",{"VOID":844},"10.1016\u002Fs1283-081x(22)46715-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X22467154",[847,862,874,886],{"id":848,"sortIndex":114,"researcher":26,"roles":849,"affiliations":850,"properties":859},"f42177e7-b479-4a2e-9318-73c4c4f0608d",[696],[851],{"id":26,"sortIndex":36,"affiliation":852,"properties":26},{"id":853,"createTime":854,"updateTime":854,"relativeEntities":855,"slug":26,"properties":856,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"447a96c6-b3eb-4b3c-b24e-d1019f48f79f","2024-02-12T14:44:19.701+00:00",[],{"title":857},{"VI":858},"Service de gynécologie obstétrique, Hôpital Bicêtre, GHU Sud, AP–HP, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France",{"title":860},{"VI":861},"E. Debras",{"id":863,"sortIndex":115,"researcher":26,"roles":864,"affiliations":865,"properties":871},"1bffe931-a68d-4358-ae05-5b3497e7d37f",[696],[866],{"id":26,"sortIndex":36,"affiliation":867,"properties":26},{"id":853,"createTime":854,"updateTime":854,"relativeEntities":868,"slug":26,"properties":869,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":870},{"VI":858},{"title":872},{"VI":873},"S. Vigoureux",{"id":875,"sortIndex":36,"researcher":26,"roles":876,"affiliations":877,"properties":883},"4109171b-e2c5-4a04-98ac-ee4dfe0f756a",[696],[878],{"id":26,"sortIndex":36,"affiliation":879,"properties":26},{"id":853,"createTime":854,"updateTime":854,"relativeEntities":880,"slug":26,"properties":881,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":882},{"VI":858},{"title":884},{"VI":885},"M.-E. Neveu",{"id":887,"sortIndex":59,"researcher":26,"roles":888,"affiliations":889,"properties":915},"3ccd3418-a9dd-409e-a1c0-f1e2849ae686",[696],[890,900,910],{"id":891,"sortIndex":114,"affiliation":892,"properties":899},"31269e30-8572-4937-97e0-a4c30526b401",{"id":893,"createTime":894,"updateTime":894,"relativeEntities":895,"slug":26,"properties":896,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"85ab7473-d560-4a7c-b8ee-07b3c7158319","2024-02-12T14:44:19.745+00:00",[],{"title":897},{"VI":898},"Centre de recherche en épidémiologie et santé des populations, Inserm, UVSQ, Université Paris-Saclay, 94807 Villejuif, France",{},{"id":901,"sortIndex":115,"affiliation":902,"properties":909},"1fd9180a-6435-497b-a139-2fe7a0e28323",{"id":903,"createTime":904,"updateTime":904,"relativeEntities":905,"slug":26,"properties":906,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"bcca5d0d-f493-42cd-8de7-5ca1467a4950","2023-12-11T17:31:33.619+00:00",[],{"title":907},{"VI":908},"Faculté de médecine Paris-Sud Saclay, 63, rue Gabriel-Péri, 94270 Le Kremlin-Bicêtre, France",{},{"id":26,"sortIndex":36,"affiliation":911,"properties":26},{"id":853,"createTime":854,"updateTime":854,"relativeEntities":912,"slug":26,"properties":913,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":914},{"VI":858},{"title":916},{"VI":917},"H. Fernandez",{"url":845,"publisher":919,"properties":927},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":920,"slug":662,"properties":921,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":924,"manageAffiliations":925,"indexDatabases":926,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":922,"title":923},{"VOID":665},{"EN":667},[],[],[],{"volume":928,"pages":930},{"VOID":929},"58",{"VOID":931},"1-21","2022-07-01",2022,{"id":935,"createTime":936,"updateTime":937,"relativeEntities":938,"slug":939,"properties":940,"entityType":688,"verifyStatus":28,"verifyTime":945,"verifyNote":946,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":947,"fullTextUrl":26,"authors":948,"publicationType":747,"publisherRelationship":949,"citationCount":26,"citationInfo":26,"publishDate":965,"publishYear":966,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"656b55c7-7728-4779-8993-38d2de1a9f68","2024-01-30T12:29:37.053+00:00","2024-12-16T06:25:12.920+00:00",[],"Tratamiento-de-los-c%C3%A1nceres-de-endometrio",{"title":941,"doi":943},{"EN":942},"Tratamiento de los cánceres de endometrio",{"VOID":944},"10.1016\u002FS1283-081X(13)65375-8","2024-12-16T06:25:12.919+00:00","Author title is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X13653758",[],{"url":947,"publisher":950,"properties":958},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":951,"slug":662,"properties":952,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":955,"manageAffiliations":956,"indexDatabases":957,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":953,"title":954},{"VOID":665},{"EN":667},[],[],[],{"volume":959,"pages":961,"issue":963},{"VOID":960},"49",{"VOID":962},"1-10",{"VOID":964},"3","2013-09-01",2013,{"id":968,"createTime":969,"updateTime":969,"relativeEntities":970,"slug":26,"properties":971,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":978,"fullTextUrl":26,"authors":979,"publicationType":747,"publisherRelationship":1019,"citationCount":26,"citationInfo":26,"publishDate":1033,"publishYear":1034,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e4ac5b66-eae3-4d43-bc88-c34a1ef5d73a","2023-12-12T03:53:07.952+00:00",[],{"references":972,"title":974,"doi":976},{"VOID":973},"Ibanez, 2000, Premature adrenarche: normal variant or forerunner of adult disease?, Endocr. Rev., 21, 671, 10.1210\u002Fer.21.6.671\nApter, 1993, Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins, J. Clin. Endocrinol. Metab., 76, 940, 10.1210\u002Fjc.76.4.940\nIbanez, 1998, Possible genesis of polycystic ovary syndrom in the periadolescent girl, Curr. Opin. Endocrinol Diab, 5, 19, 10.1097\u002F00060793-199802000-00004\nvan Hooff, 2004, Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years, Hum. Reprod., 19, 383, 10.1093\u002Fhumrep\u002Fdeh079\nLobo, 1991, Ovarian hyperandrogenism and androgen producing tumors, Endocrinol. Metab. Clin. North Am., 20, 773, 10.1016\u002FS0889-8529(18)30244-5\nYoung, 1985, Ovarian Sertoli-Leydig cell tumors: a clinicopathological analysis of 207 cases, Am. J. Surg. Pathol., 9, 543, 10.1097\u002F00000478-198508000-00001\nCaron, 1993, Androgenic granulosa cell tumor of the ovary: in vivo hormonal studies, J. Endocrinol. Invest., 16, 545, 10.1007\u002FBF03348903\nAbbott, 2002, Developmental origin of polycystic ovary syndrome-a hypothesis, J. Endocrinol., 174, 1, 10.1677\u002Fjoe.0.1740001\nStrauss, 1999, Molecular mysteries of polycystic ovary syndrome, Mol. Endocrinol., 13, 800, 10.1210\u002Fme.13.6.800\nDunaif, 1997, Insulin resistance and the polycystic ovarian syndrome: mechanism and implications for pathogenesis, Endocr. Rev., 18, 774, 10.1210\u002Fer.18.6.774\nWebber, 2003, Formation and early development of follicles in the polycystic ovary, Lancet, 362, 1017, 10.1016\u002FS0140-6736(03)14410-8\nDewailly, 1997, Definition, clinical manifestations, and prevalance of PCOS, 259\nZacur, 1997, Prolactin abnormalities in PCOS, 287\n2004, The Rotterdam ESHRE\u002FASRM sponsored PCOS consensus workshop group, Hum. Reprod., 19, 41\nBalen, 2003, Ultrasound assessment of the polycystic ovary: international consensus definitions, Hum. Reprod. Update, 9, 505, 10.1093\u002Fhumupd\u002Fdmg044\nForest, 1992, Formes non classiques dites « tardives » du déficit en 21-hydroxylase : diagnostic différentiel avec les hétérozygotes et conseil génétique, Rev. Fr. Endocrinol. Clin., 33, 47\nDewailly, 1997, Pathophysiology and clinical manifestations of nonclassic 21-hydroxylase deficiency, 173\nAzziz, 1997, Idiopathic Hirsutism: definition, prevalence and inheritance, 529\nCortet-Rudelli, 1997, Drug-induced androgen excess, 613\nNelson-DeGrave, 2004, Valproate potentiates androgen biosynthesis in human ovarien theca cells, Endocrinology, 145, 799, 10.1210\u002Fen.2003-0940\nDiamanti-Kandarakis, 1997, Cushing's disease and androgen excess, 569\nDeroubaix-Allard, 1997, Acromegaly and androgen excess, 585\nAzziz, 1997, Diagnosis, screening, and treatment of nonclassic 21-hydroxylase deficiency, 181\nSpritzer, 1990, Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia, J. Clin. Endocrinol. Metab., 70, 642, 10.1210\u002Fjcem-70-3-642\nIbanez, 2004, Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide, J. Clin. Endocrinol. Metab., 89, 4716, 10.1210\u002Fjc.2004-0047\nKorytkowski, 1995, Metabolic effects of oral contraceptives in women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 80, 3327, 10.1210\u002Fjc.80.11.3327",{"ES":975},"Hiperandrogenismo en la adolescente",{"VOID":977},"10.1016\u002Fs1283-081x(06)46492-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X06464924",[980,995,1007],{"id":981,"sortIndex":114,"researcher":26,"roles":982,"affiliations":983,"properties":992},"6cfd7a71-c611-4f3f-bcf0-f2ea5b695550",[696],[984],{"id":26,"sortIndex":36,"affiliation":985,"properties":26},{"id":986,"createTime":987,"updateTime":987,"relativeEntities":988,"slug":26,"properties":989,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"38c841f4-3384-42fa-b581-8e6f69a378a8","2023-12-12T03:53:07.978+00:00",[],{"title":990},{"VI":991},"Service de gynécologie endocrinienne et de médecine de la reproduction, centre hospitalier universitaire de Lille, hôpital Jeanne de Flandre, 2, avenue Oscar-Lambert, 59037 Lille cedex, France",{"title":993},{"VI":994},"D. Dewailly",{"id":996,"sortIndex":115,"researcher":26,"roles":997,"affiliations":998,"properties":1004},"5c0b4907-873d-4c44-a4b3-b27503c92a1e",[696],[999],{"id":26,"sortIndex":36,"affiliation":1000,"properties":26},{"id":986,"createTime":987,"updateTime":987,"relativeEntities":1001,"slug":26,"properties":1002,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1003},{"VI":991},{"title":1005},{"VI":1006},"S. Jonard",{"id":1008,"sortIndex":36,"researcher":26,"roles":1009,"affiliations":1010,"properties":1016},"200596ea-d35a-46a9-a3c0-ff3aea2f23d5",[696],[1011],{"id":26,"sortIndex":36,"affiliation":1012,"properties":26},{"id":986,"createTime":987,"updateTime":987,"relativeEntities":1013,"slug":26,"properties":1014,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1015},{"VI":991},{"title":1017},{"VI":1018},"C. Richard",{"url":978,"publisher":1020,"properties":1028},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1021,"slug":662,"properties":1022,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1025,"manageAffiliations":1026,"indexDatabases":1027,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1023,"title":1024},{"VOID":665},{"EN":667},[],[],[],{"volume":1029,"pages":1031},{"VOID":1030},"42",{"VOID":1032},"1-8","2006-01-01",2006,{"id":1036,"createTime":1037,"updateTime":1037,"relativeEntities":1038,"slug":1039,"properties":1040,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1046,"fullTextUrl":26,"authors":1047,"publicationType":747,"publisherRelationship":1296,"citationCount":26,"citationInfo":26,"publishDate":1310,"publishYear":1311,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"1517de81-de0e-4173-bcb4-5f01d1d3395b","2023-12-02T12:30:19.789+00:00",[],"Menopausia",{"references":1041,"title":1043,"doi":1044},{"VOID":1042},"Rousset-Jablonski, 2021, How to diagnose menopause? Postmenopausal women management : CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 318\nHarlow, 2007, Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging, Climacteric, 10, 112, 10.1080\u002F13697130701258838\nRandolph, 2003, Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status, J Clin Endocrinol Metab, 88, 1516, 10.1210\u002Fjc.2002-020777\nRandolph, 2011, Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period, J Clin Endocrinol Metab, 96, 746, 10.1210\u002Fjc.2010-1746\nFreeman, 2007, Association of anti-mullerian hormone levels with obesity in late reproductive-age women, Fertil Steril, 87, 101, 10.1016\u002Fj.fertnstert.2006.05.074\nGracia, 2005, The relationship between obesity and race on inhibin B during the menopause transition, Menopause, 12, 559, 10.1097\u002F01.gme.0000172268.24949.94\nHuddleston, 2010, Racial and ethnic disparities in reproductive endocrinology and infertility, Am J Obstet Gynecol, 202, 413, 10.1016\u002Fj.ajog.2009.12.020\nMaitrot-Mantelet, 2021, Differential diagnosis of vasomotor symptoms. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 329\nPalacios, 2015, Update on management of genitourinary syndrome of menopause: a practical guide, Maturitas, 82, 308, 10.1016\u002Fj.maturitas.2015.07.020\nFaubion, 2017, Genitourinary syndrome of menopause: management strategies for the clinician, Mayo Clin Proc, 92, 1842, 10.1016\u002Fj.mayocp.2017.08.019\nPortman, 2014, Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society, Menopause, 21, 1063, 10.1097\u002FGME.0000000000000329\nNappi, 2016, Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE survey, Climacteric, 19, 188, 10.3109\u002F13697137.2015.1107039\nLegendre, 2012, Urinary incontinence and menopause, Progr Urol, 22, 615, 10.1016\u002Fj.purol.2012.08.267\nGosset, 2021, Menopausal hormone therapy for the management of osteoporosis, Best Pract Res Clin Endocrinol Metab, 35, 10.1016\u002Fj.beem.2021.101551\nGrange L, Chales G, Alliot Launois F. Livre blanc des états généraux de l’ostéoporose 2016.\nPouillès, 2021, Menopause, menopause hormone therapy and osteoporosis. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 420\nBoulat, 2019, Principales évolutions de la mortalité par cause médicale sur la période 2000–2016 en France métropolitaine, Bull Epidemiol Hebd, 576\nLecoffre, 2017, L’accident vasculaire cérébral en France : patients hospitalisés pour AVC en 2014 et évolutions 2008–2014, Bull Epidemiol Hebd, 84\nGabet, 2016, Évolution temporelle du recours à la réadaptation cardiaque après un infarctus du myocarde, France, 2010–2014, Bull Epidemiol Hebd, 43, 764\nPlu-Bureau, 2021, Menopausal hormone therapy an cardiovascular risk. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 438\nHaute Autorité de santé. Cancer du sein : modalités de dépistage en fonction du risque 2014. www.has-sante.fr\u002Fjcms\u002Fpprd_2974673\u002Ffr\u002Fcancer-du-sein-modalites-specifiques-de-depistage-pour-les-femmes-a-haut-risque#toc_1_1_3.\nDuclos, 2021, Effects of physical activity and decreased sedentary behaviours in menopausal women. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 335\nLaCroix, 2017, The objective physical activity and cardiovascular disease health in older women (OPACH) study, BMC Public Health, 17, 192, 10.1186\u002Fs12889-017-4065-6\nAgence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail. Actualisation des repères du PNNS-révision des repères relatifs à l’activité physique et à la sédentarité; 2016.\nInstitut national de la santé et de la recherche médicale. Activité physique : prévention et traitement des maladies chroniques 2019.\nAmbikairajah, 2019, Fat mass changes during menopause: a meta-analysis, Am J Obstet Gynecol, 221, 393, 10.1016\u002Fj.ajog.2019.04.023\nHaute Autorité de santé. Guide de promotion, consultation et prescription médicale d’activité physique et sportive pour la santé chez les adultes 2018. www.has-sante.fr.\nLecerf, 2021, Nutritional advices for postmenopausal woman. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 349\nZiel, 1975, Increased risk of endometrial carcinoma among users of conjugated estrogens, N Engl J Med, 293, 1167, 10.1056\u002FNEJM197512042932303\nGrady, 1992, Hormone therapy to prevent disease and prolong life in postmenopausal women, Ann Intern Med, 117, 1016, 10.7326\u002F0003-4819-117-12-1016\nHulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\u002Fprogestin Replacement Study (HERS) Research Group, JAMA, 280, 605, 10.1001\u002Fjama.280.7.605\nRossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001\u002Fjama.288.3.321\nChlebowski, 2003, Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial, JAMA, 289, 3243, 10.1001\u002Fjama.289.24.3243\nBeral, 2019, Menopausal hormone therapy and 20-year breast cancer mortality, Lancet, 394, 1139, 10.1016\u002FS0140-6736(19)32033-1\nManson, 2013, Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials, JAMA, 310, 1353, 10.1001\u002Fjama.2013.278040\nManson, 2017, Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women's Health Initiative randomized trials, JAMA, 318, 927, 10.1001\u002Fjama.2017.11217\nBenkhadra, 2015, Menopausal hormone therapy and mortality: a systematic review and meta-analysis, J Clin Endocrinol Metab, 100, 4021, 10.1210\u002Fjc.2015-2238\nHa-Vinh, 2010, Individual factors and mortality associated with hormone replacement therapy in a French cohort of women from 60 to 69 years of age, J Gynecol Obstet Biol Reprod (Paris), 39, 453, 10.1016\u002Fj.jgyn.2010.06.006\nBoardman HM, Hartley L, Eisinga A, Main C, Figuls MR i, Cosp XB, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015;3:CD002229. Doi: 10.1002\u002F14651858.CD002229.pub4.\nSimin, 2017, Menopausal hormone therapy and cancer risk: an overestimated risk?, Eur J Cancer Oxf Engl, 84, 60, 10.1016\u002Fj.ejca.2017.07.012\nAnderson, 2004, Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA, 291, 1701, 10.1001\u002Fjama.291.14.1701\nCanonico, 2016, Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen, Stroke, 47, 1734, 10.1161\u002FSTROKEAHA.116.013052\nRovinski, 2018, Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: a systematic review and meta-analysis, Thromb Res, 168, 83, 10.1016\u002Fj.thromres.2018.06.014\nVinogradova, 2020, Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases, BMJ, 371, m3873, 10.1136\u002Fbmj.m3873\nCanonico, 2007, Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study, Circulation, 115, 840, 10.1161\u002FCIRCULATIONAHA.106.642280\nCanonico, 2010, Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study, Arterioscler Thromb Vasc Biol, 30, 340, 10.1161\u002FATVBAHA.109.196022\nScarabin, 2018, Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis, Climacteric, 21, 341, 10.1080\u002F13697137.2018.1446931\nCurb, 2006, Venous thrombosis and conjugated equine estrogen in women without a uterus, Arch Intern Med, 166, 772, 10.1001\u002Farchinte.166.7.772\nCushman, 2004, Estrogen plus progestin and risk of venous thrombosis, JAMA, 292, 1573, 10.1001\u002Fjama.292.13.1573\nCanonico, 2006, Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER study, J Thromb Haemost, 4, 1259, 10.1111\u002Fj.1538-7836.2006.01933.x\nSweetland, 2012, Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study, J Thromb Haemost, 10, 2277, 10.1111\u002Fj.1538-7836.2012.04919.x\nVinogradova, 2019, Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases, BMJ, 364, k4810, 10.1136\u002Fbmj.k4810\nPoudou, 2021, Benefit-risk balance of hormone replacement therapy: cancers and mortality. Postmenopausal women management - CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 462\nFournier, 2014, Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort, Breast Cancer Res Treat, 145, 535, 10.1007\u002Fs10549-014-2934-6\nCordina-Duverger, 2013, Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France, PloS One, 8, 10.1371\u002Fjournal.pone.0078016\nBeral, 2011, Breast cancer risk in relation to the interval between menopause and starting hormone therapy, J Natl Cancer Inst, 103, 296, 10.1093\u002Fjnci\u002Fdjq527\nBeral, 2003, Breast cancer and hormone-replacement therapy in the Million Women Study, Lancet, 362, 419, 10.1016\u002FS0140-6736(03)14065-2\nCollins, 2005, Breast cancer risk with postmenopausal hormonal treatment, Hum Reprod Update, 11, 545, 10.1093\u002Fhumupd\u002Fdmi028\nGrady, 1995, Hormone replacement therapy and endometrial cancer risk: a meta-analysis, Obstet Gynecol, 85, 304, 10.1016\u002F0029-7844(94)00383-O\nAllen, 2010, Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition, Am J Epidemiol, 172, 1394, 10.1093\u002Faje\u002Fkwq300\nBrinton, 2014, Menopausal hormone therapy and risk of endometrial cancer, J Steroid Biochem Mol Biol, 142, 83, 10.1016\u002Fj.jsbmb.2013.05.001\nBeresford, 1997, Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women, Lancet, 349, 458, 10.1016\u002FS0140-6736(96)07365-5\nJaakkola, 2009, Endometrial cancer in postmenopausal women using estradiol-progestin therapy, Obstet Gynecol, 114, 1197, 10.1097\u002FAOG.0b013e3181bea950\nFournier, 2014, Risks of endometrial cancer associated with different hormone replacement therapies in the E3N cohort, 1992-2008, Am J Epidemiol, 180, 508, 10.1093\u002Faje\u002Fkwu146\nLiu, 2019, Menopausal hormone replacement therapy and the risk of ovarian cancer: a meta-analysis, Front Endocrinol (Lausanne), 10, 801, 10.3389\u002Ffendo.2019.00801\nAvis, 2015, Duration of menopausal vasomotor symptoms over the menopause transition, JAMA Intern Med, 175, 531, 10.1001\u002Fjamainternmed.2014.8063\nRaccah-Tebeka, 2021, Non-hormonal alternatives for the management of menopausal hot flushes. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 373\nRance, 2013, Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes, Front Neuroendocrinol, 34, 211, 10.1016\u002Fj.yfrne.2013.07.003\nPrague, 2017, Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial, Lancet, 389, 1809, 10.1016\u002FS0140-6736(17)30823-1\nGosset, 2021, Menopause hormone treatment in practice. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 358\nDepypere, 2015, The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review, Climacteric, 18, 470, 10.3109\u002F13697137.2014.991302\nRaudaskoski, 2002, Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response, BJOG, 109, 136\nTrémollieres, 2021, Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines (short version), Gynecol Obstet Fertil Senol, 49, 305\nHaimov-Kochman, 2006, Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study, Menopause, 13, 370\nAslan, 2007, How best is to discontinue postmenopausal hormone therapy: immediate or tapered?, Maturitas, 56, 78, 10.1016\u002Fj.maturitas.2006.06.006\nLindh-Astrand, 2010, A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms, Menopause, 17, 72, 10.1097\u002Fgme.0b013e3181b397c7\nPerrone, 2013, Menopausal symptoms after the discontinuation of long-term hormone replacement therapy in women under 60: a 3-year follow-up, Gynecol Obstet Invest, 76, 38, 10.1159\u002F000351104\nMaclennan, 2004, Oral oestrogen and combined oestrogen\u002Fprogestogen therapy versus placebo for hot flushes, Cochrane Database Syst Rev, 4\nDesmarais, 2010, Managing menopausal symptoms and depression in tamoxifen users: implications of drug and medicinal interactions, Maturitas, 67, 296, 10.1016\u002Fj.maturitas.2010.08.005\nHenry, 2008, Drug interactions and pharmacogenomics in the treatment of breast cancer and depression, Am J Psychiatry, 165, 1251, 10.1176\u002Fappi.ajp.2008.08040482\nLethaby, 2013, Phytoestrogens for menopausal vasomotor symptoms, Cochrane Database Syst Rev, 12, CD001395\nSrisukho, 2019, The experience of genitourinary syndrome of menopause (GSM) among Thai postmenopausal women: the non-reporting issue, Int Urogynecol J, 30, 1843, 10.1007\u002Fs00192-019-03991-0\nSzymański, 2018, Genitourinary syndrome of menopause – is the problem solved? State of the art 2018, Prz Menopauzalny, 17, 168\nCastelo-Branco, 2005, Management of post-menopausal vaginal atrophy and atrophic vaginitis, Maturitas, 52, S46, 10.1016\u002Fj.maturitas.2005.06.014\nPinkerton, 2017, Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning, Maturitas, 100, 57, 10.1016\u002Fj.maturitas.2017.03.315\nBachmann, 2000, Diagnosis and treatment of atrophic vaginitis, Am Fam Physician, 61, 3090\nKarakoç, 2019, Genitourinary syndrome of menopause: effects on related factors, quality of life, and self-care power, Prz Menopauzalny, 18, 15\nPastore, 2004, Self-reported urogenital symptoms in postmenopausal women: Women's Health Initiative, Maturitas, 49, 292, 10.1016\u002Fj.maturitas.2004.06.019\nMac Bride, 2010, Vulvovaginal atrophy, Mayo Clin Proc, 85, 87, 10.4065\u002Fmcp.2009.0413\nCardozo, 1998, Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee, Obstet Gynecol, 92, 722\nBarnabei, 2005, Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative, Obstet Gynecol, 105, 1063, 10.1097\u002F01.AOG.0000158120.47542.18\nFantl, 1996, Efficacy of estrogen supplementation in the treatment of urinary incontinence. The Continence Program for Women Research Group, Obstet Gynecol, 88, 745, 10.1016\u002F0029-7844(96)00281-5\nRufford, 2003, A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women, Int Urogynecol J Pelvic Floor Dysfunct, 14, 78, 10.1007\u002Fs00192-003-1054-3\nSteinauer, 2005, Postmenopausal hormone therapy: does it cause incontinence?, Obstet Gynecol, 106, 940, 10.1097\u002F01.AOG.0000180394.08406.15\nHendrix, 2005, Effects of estrogen with and without progestin on urinary incontinence, JAMA, 293, 935, 10.1001\u002Fjama.293.8.935\nWaetjen, 2005, The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women, Obstet Gynecol, 106, 946, 10.1097\u002F01.AOG.0000182576.48290.6d\nSulaica, 2016, Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy, Breast Cancer Res Treat, 157, 203, 10.1007\u002Fs10549-016-3827-7\nMaris, 2021, Management of vulvovaginal atrophy: Physical therapies. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines, Gynecol Obstet Fertil Senol, 49, 414\nGambacciani, 2015, Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause, Climacteric, 18, 757, 10.3109\u002F13697137.2015.1045485\nGaspar, 2017, Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause, Lasers Surg Med, 49, 160, 10.1002\u002Flsm.22569\nCruz, 2018, Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women, Menopause, 25, 21, 10.1097\u002FGME.0000000000000955\nRuanphoo, 2020, Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial, Menopause, 27, 858, 10.1097\u002FGME.0000000000001542\nJha, 2019, The impact of vaginal laser treatment for genitourinary syndrome of menopause in breast cancer survivors: a systematic review and meta-analysis, Clin Breast Cancer, 19, e556, 10.1016\u002Fj.clbc.2019.04.007\nPreti, 2019, The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: an ICS\u002FISSVD best practice consensus document, J Low Genit Tract Dis, 23, 151, 10.1097\u002FLGT.0000000000000462\nKanis, 2005, Assessment of fracture risk, Osteoporos Int, 16, 581, 10.1007\u002Fs00198-004-1780-5\nSornay-Rendu, 2014, How to predict fragility fracture beyond 10 years? The OFELY study, J Clin Endocrinol Metab, 99, 4690, 10.1210\u002Fjc.2014-2601\nLeslie, 2011, A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world, Curr Osteoporos Rep, 9, 129, 10.1007\u002Fs11914-011-0060-5\nBriot, 2018, 2018 update of French recommendations on the management of postmenopausal osteoporosis, Joint Bone Spine, 85, 519, 10.1016\u002Fj.jbspin.2018.02.009\nHaute Autorité de santé. Les médicaments de l’ostéoporose 2019.\nRiggs, 2004, Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites, J Bone Miner Res, 19, 1945, 10.1359\u002Fjbmr.040916\nSowers, 2013, Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity, J Clin Endocrinol Metab, 98, 2854, 10.1210\u002Fjc.2012-4113\nGRIO. Actualisation 2017 des recommandations de traitement de l’ostéoporosepost ménopausique 2017. www.grio.org\u002Fdocuments\u002Fpage240\u002Frecommandations-pmo-actualisation-2017.pdf.\nWeiss, 1999, A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss. Transdermal Estradiol Investigator Group, Obstet Gynecol, 94, 330\nDelmas, 1999, A dose-ranging trial of a matrix transdermal 17beta-estradiol for the prevention of bone loss in early postmenopausal women. International Study Group, Bone, 24, 517, 10.1016\u002FS8756-3282(99)00076-9\nHeikkinen, 2000, Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens, Osteoporos Int, 11, 929, 10.1007\u002Fs001980070031\nGartlehner, 2017, Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: evidence report and systematic review for the US Preventive Services Task Force, JAMA, 318, 2234, 10.1001\u002Fjama.2017.16952\nBanks, 2004, Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women, JAMA, 291, 2212, 10.1001\u002Fjama.291.18.2212\nWasnich, 2004, Changes in bone density and turnover after alendronate or estrogen withdrawal, Menopause, 11, 622, 10.1097\u002F01.GME.0000123641.76105.B5\nGallagher, 2002, Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers, J Clin Endocrinol Metab, 87, 4914, 10.1210\u002Fjc.2002-020727\nHocké, 2021, Syndrome génito-urinaire de la ménopause (SGUM). RPC les femmes ménopausées du CNGOF et du GEMVi, Gynecol Obstr Fertil Senol, 49, 394",{"ES":1039},{"VOID":1045},"10.1016\u002Fs1283-081x(23)47976-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X23479763",[1048,1063,1075,1087,1099,1111,1123,1135,1147,1159,1176,1188,1200,1212,1224,1236,1248,1260,1272,1284],{"id":1049,"sortIndex":135,"researcher":26,"roles":1050,"affiliations":1051,"properties":1060},"ff39c540-6905-45c7-ba30-f671547b2723",[696],[1052],{"id":26,"sortIndex":36,"affiliation":1053,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1056,"slug":26,"properties":1057,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"6c598c7e-c70e-4873-95d3-10c61b40e56a","2023-12-02T12:30:19.889+00:00",[],{"title":1058},{"VI":1059},"Collège national des gynécologues et obstétriciens français, Groupe d’étude sur la ménopause et le vieillissement hormonal, Groupe de travail « Recommandation pour la pratique Clinique 2021: les femmes ménopausées », Paris, France",{"title":1061},{"VI":1062},"J.-M. Pouille",{"id":1064,"sortIndex":51,"researcher":26,"roles":1065,"affiliations":1066,"properties":1072},"716f2bd8-4a87-4c40-aaba-8ed515a100e8",[696],[1067],{"id":26,"sortIndex":36,"affiliation":1068,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1069,"slug":26,"properties":1070,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1071},{"VI":1059},{"title":1073},{"VI":1074},"N. Hamdaoui",{"id":1076,"sortIndex":53,"researcher":26,"roles":1077,"affiliations":1078,"properties":1084},"db0da6bd-a139-4ccc-ab33-5d353c7a1b2e",[696],[1079],{"id":26,"sortIndex":36,"affiliation":1080,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1081,"slug":26,"properties":1082,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1083},{"VI":1059},{"title":1085},{"VI":1086},"J. Hugon-Rodin",{"id":1088,"sortIndex":298,"researcher":26,"roles":1089,"affiliations":1090,"properties":1096},"6d30f934-d7f9-4283-9612-ac3aba3cfb0e",[696],[1091],{"id":26,"sortIndex":36,"affiliation":1092,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1093,"slug":26,"properties":1094,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1095},{"VI":1059},{"title":1097},{"VI":1098},"G. André",{"id":1100,"sortIndex":162,"researcher":26,"roles":1101,"affiliations":1102,"properties":1108},"601a1d29-553e-4a98-a5c5-7423aac86e0e",[696],[1103],{"id":26,"sortIndex":36,"affiliation":1104,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1105,"slug":26,"properties":1106,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1107},{"VI":1059},{"title":1109},{"VI":1110},"M. Duclos",{"id":1112,"sortIndex":173,"researcher":26,"roles":1113,"affiliations":1114,"properties":1120},"adb5c12d-9967-4da2-ae28-90f05034e0fe",[696],[1115],{"id":26,"sortIndex":36,"affiliation":1116,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1117,"slug":26,"properties":1118,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1119},{"VI":1059},{"title":1121},{"VI":1122},"X. Fritel",{"id":1124,"sortIndex":234,"researcher":26,"roles":1125,"affiliations":1126,"properties":1132},"48101ac1-40be-472b-979e-d0c0e14b44b2",[696],[1127],{"id":26,"sortIndex":36,"affiliation":1128,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1129,"slug":26,"properties":1130,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1131},{"VI":1059},{"title":1133},{"VI":1134},"O. Graesslin",{"id":1136,"sortIndex":336,"researcher":26,"roles":1137,"affiliations":1138,"properties":1144},"263ebcd7-675f-479a-b53d-d03642cb5a95",[696],[1139],{"id":26,"sortIndex":36,"affiliation":1140,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1141,"slug":26,"properties":1142,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1143},{"VI":1059},{"title":1145},{"VI":1146},"C. Mathelin",{"id":1148,"sortIndex":158,"researcher":26,"roles":1149,"affiliations":1150,"properties":1156},"527bbe33-b750-4d3c-b958-7a4a44069cd1",[696],[1151],{"id":26,"sortIndex":36,"affiliation":1152,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1153,"slug":26,"properties":1154,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1155},{"VI":1059},{"title":1157},{"VI":1158},"A. Gosset",{"id":1160,"sortIndex":36,"researcher":26,"roles":1161,"affiliations":1162,"properties":1173},"1778a412-5429-47f6-b380-130f2196a836",[696],[1163],{"id":26,"sortIndex":36,"affiliation":1164,"properties":26},{"id":1165,"createTime":1166,"updateTime":1167,"relativeEntities":1168,"slug":1169,"properties":1170,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"0523ed73-f6f8-4b89-9ae5-2f5e91940931","2023-12-02T12:30:19.804+00:00","2025-06-11T18:20:31.093+00:00",[],"Service-de-gyn%C3%A9cologie-obst%C3%A9trique-m%C3%A9decine-de-la-reproduction-H%C3%B4pital-Tenon-AP-HP-Sorbonne-Universit%C3%A9-4-rue-de-la-Chine-75020-Paris-France",{"title":1171},{"VI":1172},"Service de gynécologie obstétrique médecine de la reproduction, Hôpital Tenon, AP–HP, Sorbonne Université, 4 rue de la Chine, 75020 Paris, France",{"title":1174},{"VI":1175},"N. Chabbert-Buffet",{"id":1177,"sortIndex":59,"researcher":26,"roles":1178,"affiliations":1179,"properties":1185},"a16e47f4-64e1-414f-96f9-f8b4be1318e1",[696],[1180],{"id":26,"sortIndex":36,"affiliation":1181,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1182,"slug":26,"properties":1183,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1184},{"VI":1059},{"title":1186},{"VI":1187},"C. Rousset-Jablonski",{"id":1189,"sortIndex":124,"researcher":26,"roles":1190,"affiliations":1191,"properties":1197},"2df716cb-0ba4-4e19-afa4-b9f7208f1bad",[696],[1192],{"id":26,"sortIndex":36,"affiliation":1193,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1194,"slug":26,"properties":1195,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1196},{"VI":1059},{"title":1198},{"VI":1199},"P. Lopes",{"id":1201,"sortIndex":116,"researcher":26,"roles":1202,"affiliations":1203,"properties":1209},"d04c02cd-1fab-4835-b3b9-dc4fccecd5d5",[696],[1204],{"id":26,"sortIndex":36,"affiliation":1205,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1206,"slug":26,"properties":1207,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1208},{"VI":1059},{"title":1210},{"VI":1211},"E. Maris",{"id":1213,"sortIndex":114,"researcher":26,"roles":1214,"affiliations":1215,"properties":1221},"4db97be7-9be9-4075-b6e0-4c5b6a374750",[696],[1216],{"id":26,"sortIndex":36,"affiliation":1217,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1218,"slug":26,"properties":1219,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1220},{"VI":1059},{"title":1222},{"VI":1223},"G. Plu-Bureau",{"id":1225,"sortIndex":111,"researcher":26,"roles":1226,"affiliations":1227,"properties":1233},"8329402b-35cf-4eb6-b7dd-aa8527e8ee2a",[696],[1228],{"id":26,"sortIndex":36,"affiliation":1229,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1230,"slug":26,"properties":1231,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1232},{"VI":1059},{"title":1234},{"VI":1235},"J.-M. Lecerf",{"id":1237,"sortIndex":115,"researcher":26,"roles":1238,"affiliations":1239,"properties":1245},"7267bb95-824a-475c-bf1c-9773b9a59886",[696],[1240],{"id":26,"sortIndex":36,"affiliation":1241,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1242,"slug":26,"properties":1243,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1244},{"VI":1059},{"title":1246},{"VI":1247},"F. Trémollieres",{"id":1249,"sortIndex":356,"researcher":26,"roles":1250,"affiliations":1251,"properties":1257},"20d4868c-d9e8-4eae-bd04-032e8f16942e",[696],[1252],{"id":26,"sortIndex":36,"affiliation":1253,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1254,"slug":26,"properties":1255,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1256},{"VI":1059},{"title":1258},{"VI":1259},"G. Robin",{"id":1261,"sortIndex":103,"researcher":26,"roles":1262,"affiliations":1263,"properties":1269},"831a096c-14b8-429b-97de-3fcf4b95f1b5",[696],[1264],{"id":26,"sortIndex":36,"affiliation":1265,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1266,"slug":26,"properties":1267,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1268},{"VI":1059},{"title":1270},{"VI":1271},"L. Maitrot-Mantelet",{"id":1273,"sortIndex":50,"researcher":26,"roles":1274,"affiliations":1275,"properties":1281},"44247774-6183-48ef-9860-738229f683b6",[696],[1276],{"id":26,"sortIndex":36,"affiliation":1277,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1278,"slug":26,"properties":1279,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1280},{"VI":1059},{"title":1282},{"VI":1283},"G. Boutet",{"id":1285,"sortIndex":52,"researcher":26,"roles":1286,"affiliations":1287,"properties":1293},"c151b938-5903-41bb-ac5c-c59a7172515b",[696],[1288],{"id":26,"sortIndex":36,"affiliation":1289,"properties":26},{"id":1054,"createTime":1055,"updateTime":1055,"relativeEntities":1290,"slug":26,"properties":1291,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1292},{"VI":1059},{"title":1294},{"VI":1295},"C. Hocké",{"url":1046,"publisher":1297,"properties":1305},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1298,"slug":662,"properties":1299,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1302,"manageAffiliations":1303,"indexDatabases":1304,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1300,"title":1301},{"VOID":665},{"EN":667},[],[],[],{"volume":1306,"pages":1308},{"VOID":1307},"59",{"VOID":1309},"1-13","2023-09-01",2023,{"id":1313,"createTime":1314,"updateTime":1314,"relativeEntities":1315,"slug":1316,"properties":1317,"entityType":688,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1324,"fullTextUrl":26,"authors":1325,"publicationType":747,"publisherRelationship":1371,"citationCount":26,"citationInfo":26,"publishDate":1384,"publishYear":1385,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"a1761522-6120-48d3-bcb7-4a62c847c458","2023-11-30T06:21:53.407+00:00",[],"F%C3%A1rmacos-tocol%C3%ADticos",{"references":1318,"title":1320,"doi":1322},{"VOID":1319},"Sentilhes, 2016, Recommandations pour la pratique clinique : prévention de la prématurité spontanée et de ses conséquences (hors rupture des membranes) –Texte des recommandations, J Gynecol Obstet Biol Reprod, 45, 1446, 10.1016\u002Fj.jgyn.2016.09.011\nDoret, 2016, La tocolyse en cas de menace d’accouchement prématuré à membranes intactes, J Gynecol Obstet Biol Reprod, 45, 1374, 10.1016\u002Fj.jgyn.2016.09.018\nNeilson, 2014, Betamimetics for inhibiting preterm labour, Cochrane Database Syst Rev, CD004352\nHaas, 2012, Tocolytic therapy for preterm delivery: systematic review and network meta-analysis, BMJ, 345, e6226, 10.1136\u002Fbmj.e6226\nFlenady, 2014, Oxytocin receptor antagonists for inhibiting preterm labour, Cochrane Database Syst Rev, CD004452\nHaas, 2009, Tocolytic therapy: a meta-analysis and decision analysis, Obstet Gynecol, 113, 585, 10.1097\u002FAOG.0b013e318199924a\nConde-Agudelo, 2011, Nifedipine in the management of preterm labor: a systematic review and meta-analysis, Am J Obstet Gynecol, 204, 10.1016\u002Fj.ajog.2010.11.038\nTsatsaris, 2001, Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis, Obstet Gynecol, 97, 840\nCoomarasamy, 2002, Oxytocin antagonists for tocolysis in preterm labour -- a systematic review, Med Sci Monit, 8, RA268\nLeveno, 1986, Single-centre randomised trial of ritodrine hydrochloride for preterm labour, Lancet, 1, 1293, 10.1016\u002FS0140-6736(86)91219-5\nde Heus, 2009, Adverse drug reactions to tocolytic treatment for preterm labour: prospective cohort study, BMJ, 338, b744, 10.1136\u002Fbmj.b744\nMabie, 1983, Pulmonary edema induced by betamimetic drugs, South Med J, 76, 1354, 10.1097\u002F00007611-198311000-00007\nDudenhausen, 2006, “Normal” pregnancy with adverse events on initial tocolytic treatment, BJOG, 113, 116, 10.1111\u002Fj.1471-0528.2006.01138.x\nPaternoster, 2004, Maternal complications from tocolytic treatment with ritodrine. Three cases of pulmonary edema, Minerva Ginecol, 56, 491\nKaraman, 2004, Pulmonary edema after ritodrine therapy during pregnancy and subsequent cesarean section with epidural anesthesia, Clin Exp Obstet Gynecol, 31, 67\nHamel, 2002, [Pulmonary edema and tocolysis with beta-agonists], Rev Mal Respir, 19, 241\nMilos, 1988, Maternal pulmonary edema complicating beta-adrenergic therapy of preterm labor, AJR Am J Roentgenol, 151, 917, 10.2214\u002Fajr.151.5.917\nEvron, 1983, [Pulmonary edema occurring after isoxsuprine treatment for preterm labor], Harefuah, 105, 287\nBenedetti, 1982, Maternal pulmonary edema during premature labor inhibition, Obstet Gynecol, 59\nStubblefield, 1978, Pulmonary edema occurring after therapy with dexamethasone and terbutaline for premature labor: a case report, Am J Obstet Gynecol, 132, 341, 10.1016\u002F0002-9378(78)90907-9\nNagey, 1982, Pulmonary complications of isoxsuprine therapy in the gravida, Obstet Gynecol, 59\nJacobs, 1980, Maternal pulmonary edema resulting from betamimetic and glucocorticoid therapy, Obstet Gynecol, 56, 56\nGuernsey, 1981, Pulmonary edema associated with the use of betamimetic agents in preterm labor, Am J Hosp Pharm, 38, 1942\nBrosset, 1982, Cardiac complications of ritodrine in mother and baby, Lancet, 1, 1468, 10.1016\u002FS0140-6736(82)92476-X\nCarson, 2002, Atrial fibrillation in pregnancy associated with oral terbutaline, Obstet Gynecol, 100, 1096\nAbramovici, 1980, Maternal pulmonary edema occurring after therapy with ritodrine for premature uterine contractions, Acta Obstet Gynecol Scand, 59, 555, 10.3109\u002F00016348009155450\nDordević, 2002, [Successful resuscitation of a patient with prolonged tocolytic therapy and an emergency cesarean section], Vojnosanit Pregl, 59, 325, 10.2298\u002FVSP0203325D\nMagnus, 1987, [Myocardial infarction during tocolysis with sympathomimetics], Tidsskr Nor Laegeforen, 107, 943\nKotoujansky, 1985, [Tocolysis using salbutamol in cases of cardiac rhythm disorders in the mother. Apropos of 4 cases], J Gynecol Obstet Biol Reprod, 14, 915\nZhang, 2014, Ritodrine-induced agranulocytosis in pregnancy, J Obstet Gynaecol, 34, 533, 10.3109\u002F01443615.2014.914481\nYasuda, 2012, Agranulocytosis associated with intravenous ritodrine hydrochloride therapy: two case reports by different mechanisms, J Obstet Gynaecol Res, 38, 574, 10.1111\u002Fj.1447-0756.2011.01756.x\nKikkawa, 2008, Granulocyte-colony stimulating factor for the treatment of ritodrine-induced neutropenia, J Obstet Gynaecol Res, 34, 286, 10.1111\u002Fj.1447-0756.2008.00773.x\nMuro, 1991, Ritodrine-induced agranulocytosis, Int J Gynaecol Obstet, 36, 329, 10.1016\u002F0020-7292(91)90488-Q\nVerriello, 2009, Rhabdomyolysis caused by tocolytic therapy with ritodrine hydrochloride, Neuromuscul Disord, 19, 718, 10.1016\u002Fj.nmd.2009.06.364\nNasu, 2006, Rhabdomyolysis caused by tocolysis with oral ritodrine hydrochloride in a pregnant patient with myotonic dystrophy, Gynecol Obstet Invest, 1, 53, 10.1159\u002F000088531\nRosene, 1982, Cerebral ischemia associated with parenteral terbutaline use in pregnant migraine patients, Am J Obstet Gynecol, 143, 405, 10.1016\u002F0002-9378(82)90081-3\nHudgens, 1993, Sudden death associated with terbutaline sulfate administration, Am J Obstet Gynecol, 169, 120, 10.1016\u002F0002-9378(93)90144-8\nMilliez, 1980, A case report of maternal death associated with betamimetics and betamethasone administration in premature labor, Eur J Obstet Gynecol Reprod Biol, 11, 95, 10.1016\u002F0028-2243(80)90014-3\nRäsänen, 1990, The effects of ritodrine infusion on fetal myocardial function and fetal hemodynamics, Acta Obstet Gynecol Scand, 69, 487, 10.3109\u002F00016349009013323\nGokay, 2001, Changes in fetal hemodynamics with ritodrine tocolysis, Ultrasound Obstet Gynecol, 18, 44, 10.1046\u002Fj.1469-0705.2001.00453.x\nBrar, 1988, Maternal and fetal blood flow velocity waveforms in patients with preterm labor: effect of tocolytics, Obstet Gynecol, 72, 209\nWitter, 2009, In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes, Am J Obstet Gynecol, 201, 553, 10.1016\u002Fj.ajog.2009.07.010\nConnors, 2005, Beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins, J Child Neurol, 20, 876, 10.1177\u002F08830738050200110401\nPitzer, 2001, Child development after maternal tocolysis with beta-sympathomimetic drugs, Child Psychiatry Hum Dev, 31, 165, 10.1023\u002FA:1026419720410\nHadders-Algra, 1986, Long-term follow-up of children prenatally exposed to ritodrine, Br J Obstet Gynaecol, 93, 156, 10.1111\u002Fj.1471-0528.1986.tb07880.x\nFreysz, 1977, A long term evaluation of infants who received a beta-mimetic drug while in utero, J Perinat Med, 5, 94, 10.1515\u002Fjpme.1977.5.2.94\nGidaya, 2016, In utero exposure to β-2-adrenergic receptor agonist drugs and risk for autism spectrum disorders, Pediatrics, 137, e20151316, 10.1542\u002Fpeds.2015-1316\nNICE. Preterm Labour and Birth [Internet]. London: National Institute for Health and Care Excellence (UK); 2015.\nRomero, 2000, An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue, Am J Obstet Gynecol, 182, 1173, 10.1067\u002Fmob.2000.95834\nvan Vliet, 2016, Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial, Lancet, 387, 2117, 10.1016\u002FS0140-6736(16)00548-1\nAl-Omari, 2006, Atosiban and nifedipine in acute tocolysis: a comparative study, Eur J Obstet Gynecol Reprod Biol, 128, 129, 10.1016\u002Fj.ejogrb.2005.12.010\nSalim, 2012, Nifedipine compared with atosiban for treating preterm labor: a randomized controlled trial, Obstet Gynecol, 120, 1323, 10.1097\u002FAOG.0b013e3182755dff\nSeinen, 2013, [Maternal pulmonary oedema due to the use of atosiban in cases of multiple gestation], Ned Tijdschr Geneeskd, 157, A5316\nFernández, 2011, Severe non-cardiogenic pulmonary oedema secondary to atosiban and steroids, Int J Obstet Anesth, 20, 189, 10.1016\u002Fj.ijoa.2010.09.003\nFerguson, 1990, A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal, and neonatal outcome, Am J Obstet Gynecol, 163, 105, 10.1016\u002FS0002-9378(11)90679-6\nSilberschmidt, 2008, Nifedipine concentration in maternal and umbilical cord blood after nifedipine gastrointestinal therapeutic system for tocolysis, BJOG, 115, 480, 10.1111\u002Fj.1471-0528.2007.01630.x\nClouqueur, 2015, [Adverse effects of calcium channels blockers used as tocolytic treatment], J Gynecol Obstet Biol Reprod, 44, 341, 10.1016\u002Fj.jgyn.2014.12.012\nFlenady, 2014, Calcium channel blockers for inhibiting preterm labour and birth, Cochrane Database Syst Rev, CD002255\nAra, 2008, A prospective randomised trial of nifedipine versus placebo in preterm labour, Bangladesh J Obstet Gynaecol, 23, 61, 10.3329\u002Fbjog.v23i2.4962\nZhang, 2002, [Clinical observations on the prevention and treatment of premature labor with nifedipine], Hua Xi Yi Ke Da Xue Xue Bao, 33, 288\nBejan-Angoulvant, 2015, [Calcium channel blockers pharmacology and their use as tocolytics], J Gynecol Obstet Biol Reprod, 44, 305, 10.1016\u002Fj.jgyn.2014.12.010\nParant, 2015, [Use of calcium channel blockers (CCB) for tocolysis in France and abroad], J Gynecol Obstet Biol Reprod, 44, 312, 10.1016\u002Fj.jgyn.2014.12.016\nLe Ray, 2010, [Nifedipine or nicardipine in management of threatened preterm delivery: an observational population-based study], J Gynecol Obstet Biol Reprod, 39, 490, 10.1016\u002Fj.jgyn.2010.04.004\nLaas, 2012, [Comparison of the rate of maternal complications of nifedipine and nicardipine in cases of preterm labor: historical study on two consecutive periods], J Gynecol Obstet Biol Reprod, 41, 631, 10.1016\u002Fj.jgyn.2012.04.020\nMcGuirl J, Arzuaga B, Lee BH. Antenatal calcium channel blocker exposure and subsequent patent ductus arteriosus in extremely low-birth-weight infants. Pediatr Cardiol 2012;33:60–4.\nSmith, 2007, Randomized double-blind placebo-controlled trial of transdermal nitroglycerin for preterm labor, Am J Obstet Gynecol, 196, 10.1016\u002Fj.ajog.2006.10.868\nHaghighi, 2005, Isosorbide dinitrate for treatment of preterm labor, Int J Gynaecol Obstet, 89, 274, 10.1016\u002Fj.ijgo.2005.03.004\nDuckitt, 2014, Nitric oxide donors for treating preterm labour, Cochrane Database Syst Rev, CD002860\nAmorim, 2009, [Transdermal nitroglycerin versus oral nifedipine administration for tocolysis: a randomized clinical trial], Rev Bras Ginecol Obstet, 31, 552\nCrowther, 2014, Magnesium sulphate for preventing preterm birth in threatened preterm labour, Cochrane Database Syst Rev, CD001060\nReinebrant, 2015, Cyclo-oxygenase (COX) inhibitors for treating preterm labour, Cochrane Database Syst Rev, CD001992\nErny, 1986, The effects of oral administration of progesterone for premature labor, Am J Obstet Gynecol, 154, 525, 10.1016\u002F0002-9378(86)90595-8\nChawanpaiboon, 2011, Comparison of success rate of nifedipine, progesterone, and bed rest for inhibiting uterine contraction in threatened preterm labor, J Obstet Gynaecol Res, 37, 787, 10.1111\u002Fj.1447-0756.2010.01434.x\nSu, 2014, Progestational agents for treating threatened or established preterm labour, Cochrane Database Syst Rev, CD006770\nKCE. Prévention de l’accouchement prématuré chez les femmes à risque – Évaluation de quelques mesures courantes. https:\u002F\u002Fkce.fgov.be\u002Ffr\u002Fpr%C3%A9vention-de-l%E2%80%99accouchement-pr%C3%A9matur%C3%A9-chez-les-femmes-%C3%A0-risque-%E2%80%93-evaluation-de-quelques-mesures.\n[No authors listed]. Practice Bulletin No. 159: Management of Preterm Labor. Obstet Gynecol 2016;127:e29–38.\nOrganisation mondiale de la santé. Recommandations de l’OMS sur les interventions visant à améliorer l’issue des naissances prématurées. Août 2015. http:\u002F\u002Fapps.who.int\u002Firis\u002Fbitstream\u002F10665\u002F200219\u002F1\u002FWHO_RHR_15.16_fre.pdf?ua=1.\nVeille, 1985, Maternal cardiovascular adaptations to twin pregnancy, Am J Obstet Gynecol, 153, 261, 10.1016\u002FS0002-9378(85)80109-5\nDodd, 2012, Oral betamimetics for maintenance therapy after threatened preterm labour, Cochrane Database Syst Rev, 12, CD003927\nChawanpaiboon, 2014, Terbutaline pump maintenance therapy after threatened preterm labour for reducing adverse neonatal outcomes, Cochrane Database Syst Rev, CD010800\nHan, 2013, Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD000940\nNaik Gaunekar, 2013, Maintenance therapy with calcium channel blockers for preventing preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD004071\nRoos, 2013, Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial, JAMA, 309, 41, 10.1001\u002Fjama.2012.153817\nParry, 2014, The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour, Aust N Z J Obstet Gynaecol, 54, 231, 10.1111\u002Fajo.12179\nPapatsonis, 2013, Maintenance therapy with oxytocin antagonists for inhibiting preterm birth after threatened preterm labour, Cochrane Database Syst Rev, CD005938\nVogel, 2014, Combination of tocolytic agents for inhibiting preterm labour, Cochrane Database Syst Rev, CD006169\nManuck, 2015, Tocolysis for women with early spontaneous preterm labor and advanced cervical dilation, Obstet Gynecol, 126, 954, 10.1097\u002FAOG.0000000000001095\nde Veciana, 1995, Tocolysis in advanced preterm labor: impact on neonatal outcome, Am J Perinatol, 12, 294, 10.1055\u002Fs-2007-994478\nAmon, 2000, Tocolysis with advanced cervical dilatation, Obstet Gynecol, 95, 358\nKlauser, 2016, Tocolysis in women with advanced preterm labor: a secondary analysis of a randomized clinical trial, J Matern Fetal Neonatal Med, 29, 696, 10.3109\u002F14767058.2015.1018171",{"ES":1321},"Fármacos tocolíticos",{"VOID":1323},"10.1016\u002Fs1283-081x(19)42003-1","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X19420031",[1326,1341,1356],{"id":1327,"sortIndex":36,"researcher":26,"roles":1328,"affiliations":1329,"properties":1338},"b43820b1-e054-4ee3-ac76-3d9ee61394fc",[696],[1330],{"id":26,"sortIndex":36,"affiliation":1331,"properties":26},{"id":1332,"createTime":1333,"updateTime":1333,"relativeEntities":1334,"slug":26,"properties":1335,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"28f2c27d-a0a5-47ac-889a-e2fbc3dcd77a","2023-11-30T06:21:53.446+00:00",[],{"title":1336},{"VI":1337},"Service de gynécologie obstétrique, Hôpital Femme-Mère-Enfant, Hospices civils de Lyon, 59, boulevard Pinel, 69677 Bron cedex, France",{"title":1339},{"VI":1340},"M. Doret",{"id":1342,"sortIndex":115,"researcher":26,"roles":1343,"affiliations":1344,"properties":1353},"5319dc5e-c1f6-44cb-b32a-142b758b5503",[696],[1345],{"id":26,"sortIndex":36,"affiliation":1346,"properties":26},{"id":1347,"createTime":1348,"updateTime":1348,"relativeEntities":1349,"slug":26,"properties":1350,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"20b165d4-879a-440b-aff8-f3bb9f981f1d","2023-11-30T06:21:53.467+00:00",[],{"title":1351},{"VI":1352},"Service de gynécologie-obstétrique, Hôpital Trousseau, AP–HP, Paris, France",{"title":1354},{"VI":1355},"G. Kayem",{"id":1357,"sortIndex":114,"researcher":26,"roles":1358,"affiliations":1359,"properties":1368},"112b2d8a-62db-4ba9-8b3a-0c80b10d7b98",[696],[1360],{"id":26,"sortIndex":36,"affiliation":1361,"properties":26},{"id":1362,"createTime":1363,"updateTime":1363,"relativeEntities":1364,"slug":26,"properties":1365,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4c570d3a-0ed7-4288-ab4e-2ec370f4f17a","2023-11-30T06:21:53.515+00:00",[],{"title":1366},{"VI":1367},"Service de gynécologie-obstétrique, Hôpital Pellegrin, CHU de Bordeaux, place Amélie-Raba-Léon, 33076 Bordeaux cedex, France",{"title":1369},{"VI":1370},"L. Sentilhes",{"url":1324,"publisher":1372,"properties":1380},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1373,"slug":662,"properties":1374,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1377,"manageAffiliations":1378,"indexDatabases":1379,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1375,"title":1376},{"VOID":665},{"EN":667},[],[],[],{"volume":1381,"pages":1383},{"VOID":1382},"55",{"VOID":1032},"2019-06-01",2019,{"id":1387,"createTime":1388,"updateTime":1389,"relativeEntities":1390,"slug":1391,"properties":1392,"entityType":688,"verifyStatus":25,"verifyTime":1389,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1399,"fullTextUrl":26,"authors":1400,"publicationType":747,"publisherRelationship":1430,"citationCount":26,"citationInfo":26,"publishDate":1444,"publishYear":1445,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"43acb280-1c0c-4866-91c0-8788dadce0ac","2024-01-17T13:36:24.521+00:00","2024-12-29T17:06:57.149+00:00",[],"Infecciones-de-transmisi%C3%B3n-sexual",{"references":1393,"title":1395,"doi":1397},{"VOID":1394},"Newman, 2015, Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting, PLoS One, 10, 10.1371\u002Fjournal.pone.0143304\nLa Ruche, 2014, Évolution des résistances du gonocoque aux antibiotiques en France de 2001 à 2012, Bull Epidemiol Hebd, 5, 93\nBulletin des réseaux de surveillance des IST : données au 31 décembre 2013. INVS; novembre 2014.\nBulletin des réseaux de surveillance des infections sexuellement transmissibles (IST) - Rénago, Rénachla et RésIST : données au 31 décembre 2012. Saint-Maurice : InVS, 2015, consultation en ligne : http:\u002F\u002Fwww.invs.sante.fr\u002FDossiers-thematiques\u002FMaladies-infectieuses\u002FVIH-sida-IST\u002FInfections-sexuellement-transmissibles-IST\u002FBulletins-des-reseaux-de-surveillance-des-IST.\nBowen, 2015, Increase in incidence of congenital syphilis—United States, 2012-2014, MMWR Morb Mortal Wkly Rep, 64, 1241, 10.15585\u002Fmmwr.mm6444a3\nBerwald, 2009, Self-administered vaginal swabs are a feasible alternative to physician-assisted cervical swabs for sexually transmitted infection screening in the emergency department, Acad Emerg Med, 16, 360, 10.1111\u002Fj.1553-2712.2009.00359.x\nMiettinen, 1993, Test performance of erythrocyte sedimentation rate and C-reactive protein in assessing the severity of acute pelvic inflammatory disease, Am J Obstet Gynecol, 169, 1143, 10.1016\u002F0002-9378(93)90271-J\nAlthaus, 2012, Towards more robust estimates of the transmissibility of Chlamydia trachomatis, Sex Transm Dis, 39, 402, 10.1097\u002FOLQ.0b013e318248a550\nDavies, 2013, Risk of pelvic inflammatory disease after Chlamydia infection in a prospective cohort of sex workers, Sex Transm Dis, 40, 230, 10.1097\u002FOLQ.0b013e31827b9d75\nDavies, 2014, Heterogeneity in risk of pelvic inflammatory diseases after Chlamydia infection: a population-based study in Manitoba, Canada, J Infect Dis, 210, S549, 10.1093\u002Finfdis\u002Fjiu483\nHammerschlag, 1989, Chlamydial infections, J Pediatr, 114, 727, 10.1016\u002FS0022-3476(89)80128-3\nLanjouw, 2016, 2015 European guideline on the management of Chlamydia trachomatis infections, Int J STD AIDS, 27, 333, 10.1177\u002F0956462415618837\nLand, 2006, Chlamydia antibody testing in subfertile women, Drugs Today, 42, 35\nRenault, 2011, Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection, Sex Health, 8, 69, 10.1071\u002FSH10030\nChan, 2016, Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature, Infect Dis Obstet Gynecol, 2016, 5758387, 10.1155\u002F2016\u002F5758387\nTrebach, 2015, Neisseria gonorrhoeae and Chlamydia trachomatis among women reporting extragenital exposures, Sex Transm Dis, 42, 233, 10.1097\u002FOLQ.0000000000000248\nTully, 1981, A newly discovered mycoplasma in the human urogenital tract, Lancet, 1, 1288, 10.1016\u002FS0140-6736(81)92461-2\nTaylor-Robinson, 2011, Mycoplasma genitalium: from chrysalis to multicolored butterfly, Clin Microbiol Rev, 24, 498, 10.1128\u002FCMR.00006-11\nHaggerty, 2011, Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease, Infect Dis Obstet Gynecol, 2006\nOliphant, 2016, Pelvic inflammatory disease associated with Chlamydia trachomatis but not Mycoplasma genitalium in New Zealand, Sex Health, 13, 43, 10.1071\u002FSH14238\nLillis, 2011, Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women, J Clin Microbiol, 49, 1990, 10.1128\u002FJCM.00129-11\nJernberg, 2008, Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study, Int J STD AIDS, 19, 676, 10.1258\u002Fijsa.2008.008038\nJensen, 2016, 2016 European guideline on Mycoplasma genitalium infections, J Eur Acad Dermatol Venereol, 30, 1650, 10.1111\u002Fjdv.13849\nKokkayil, 2015, Ureaplasma: current perspectives, Indian J Med Microbiol, 33, 205, 10.4103\u002F0255-0857.154850\nZdrodowska-Stefanow, 2006, Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases, Adv Med Sci, 51, 250\nKataoka, 2006, Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy, J Clin Microbiol, 44, 51, 10.1128\u002FJCM.44.1.51-55.2006\nSilver, 2014, Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis, Sex Transm Dis, 41, 369, 10.1097\u002FOLQ.0000000000000134\nWorld Health Organisation. Sexually transmitted infections management guidelines 1999. http:\u002F\u002Fwww.who.int\u002FHIV_AIDS.\nMark, 2008, Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults, MJ Infect Dis, 198, 1141, 10.1086\u002F591913\nTronstein, 2011, Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection, JAMA, 305, 1441, 10.1001\u002Fjama.2011.420\nBrown, 2003, Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant, JAMA, 289, 203, 10.1001\u002Fjama.289.2.203\nCorey, 2004, Once-daily valacyclovir to reduce the risk of transmission of genital herpes, N Engl J Med, 350, 11, 10.1056\u002FNEJMoa035144\nCentre national de référence des Papillomavirus humains (CNR HPV), Institut Pasteur, 2016.\nDuport, 2004, Le cancer du col de l’utérus : état des connaissances en 2014, Bull Epidemiol Hebd\nMonsonego, 2006\nAlain, 2010, Papillomavirus : les virus et la physiopathologie de l’infection, Med Ther Pediatr, 13, 5\nGavillon, 2010, How did I contract human Papillomavirus (HPV)?, Gynecol Obstet Fertil, 38, 199, 10.1016\u002Fj.gyobfe.2010.01.003\nWiner, 2006, Condom use and the risk of genital human papillomavirus infection in young women, N Engl J Med, 354, 2645, 10.1056\u002FNEJMoa053284\nHuman Papillomaviruses, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans (vol. 90), 2007.\nSyrjänen, 2000\nKoutsky, 1997, Epidemiology of genital human papillomavirus infection, Am J Med, 102, 3, 10.1016\u002FS0002-9343(97)00177-0\nD'Souza, 2007, Case-control study of human papillomavirus and oropharyngeal cancer, N Engl J Med, 356, 1944, 10.1056\u002FNEJMoa065497\nFerenczy, 1995, Epidemiology and clinical pathophysiology of condylomata acuminate, Am J Obstet Gynecol, 172, 1331, 10.1016\u002F0002-9378(95)90399-2\nCox, 2006, The development of cervical cancer and its precursors: what is the role of human papillomavirus infection?, Curr Opin Obstet Gynecol, 18\nWang, 2003, Viral and host factors in human papillomavirus persistence and progression, J Natl Cancer Inst Monogr, 31, 35, 10.1093\u002Foxfordjournals.jncimonographs.a003480\nIversen, 1998, Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway, Obstet Gynecol, 91, 969\nCarter, 1993, Invasive vulvar tumors in young women- a disease of the immunosuppressed?, Gynecol Oncol, 51, 307, 10.1006\u002Fgyno.1993.1295\nANAES. Évaluation de l’intérêt de la recherche des papillomavirus humains (HPV) dans le dépistage des lésions précancéreuses et cancéreuses du col de l’utérus. Mai 2004.\nTamalet, 2016, Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France, J Clin Virol, 78, 102, 10.1016\u002Fj.jcv.2016.02.027\nHaut Conseil de la Santé Publique : Avis sur les infections à HPV des jeunes filles : révision de l’âge de vaccination. Janvier 2013.\nChemlal, 2013\nJoura, 2015, A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women, N Engl J Med, 372, 711, 10.1056\u002FNEJMoa1405044\nHaute Autorité de santé. État des lieux et recommandations pour le dépistage du cancer du col de l’utérus en France. 2010.",{"ES":1396},"Infecciones de transmisión sexual",{"VOID":1398},"10.1016\u002Fs1283-081x(18)89322-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X18893225",[1401,1418],{"id":1402,"sortIndex":36,"researcher":26,"roles":1403,"affiliations":1404,"properties":1415},"b7870109-cf54-4554-9ca5-b93c5f621fa4",[696],[1405],{"id":26,"sortIndex":36,"affiliation":1406,"properties":26},{"id":1407,"createTime":1408,"updateTime":1409,"relativeEntities":1410,"slug":1411,"properties":1412,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"06538763-c522-4171-81a3-5c78cfc57486","2024-01-10T16:43:12.676+00:00","2025-06-11T19:24:55.428+00:00",[],"Institut-Fournier-25-boulevard-Saint-Jacques-75014-Paris-France",{"title":1413},{"VI":1414},"Institut Fournier, 25, boulevard Saint-Jacques, 75014 Paris, France",{"title":1416},{"VI":1417},"J.-M. Bohbot",{"id":1419,"sortIndex":115,"researcher":26,"roles":1420,"affiliations":1421,"properties":1427},"c4367592-9996-4f01-972b-815ca8971b61",[696],[1422],{"id":26,"sortIndex":36,"affiliation":1423,"properties":26},{"id":1407,"createTime":1408,"updateTime":1409,"relativeEntities":1424,"slug":1411,"properties":1425,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1426},{"VI":1414},{"title":1428},{"VI":1429},"A. Marchal",{"url":1399,"publisher":1431,"properties":1439},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1432,"slug":662,"properties":1433,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1436,"manageAffiliations":1437,"indexDatabases":1438,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1434,"title":1435},{"VOID":665},{"EN":667},[],[],[],{"volume":1440,"pages":1442},{"VOID":1441},"54",{"VOID":1443},"1-9","2018-06-01",2018,{"id":1447,"createTime":1448,"updateTime":1449,"relativeEntities":1450,"slug":1451,"properties":1452,"entityType":688,"verifyStatus":25,"verifyTime":1449,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1457,"fullTextUrl":26,"authors":1458,"publicationType":747,"publisherRelationship":1523,"citationCount":26,"citationInfo":26,"publishDate":1536,"publishYear":1537,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"e0fc4b05-1ae9-4221-a4cc-32f06e815188","2024-01-30T04:06:19.148+00:00","2025-01-30T12:26:26.507+00:00",[],"Moduladores-selectivos-de-los-receptores-estrog%C3%A9nicos-MSRE-",{"title":1453,"doi":1455},{"EN":1454},"Moduladores selectivos de los receptores estrogénicos (MSRE)",{"VOID":1456},"10.1016\u002FS1283-081X(16)79119-3","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X16791193",[1459,1484,1499,1511],{"id":1460,"sortIndex":36,"researcher":26,"roles":1461,"affiliations":1462,"properties":1482},"264b68e2-46fc-4f75-a5e4-666460fd12ac",[696],[1463,1471],{"id":26,"sortIndex":36,"affiliation":1464,"properties":26},{"id":1465,"createTime":1466,"updateTime":1466,"relativeEntities":1467,"slug":26,"properties":1468,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"691ebe81-ca0d-4d96-853d-178b8c221fdb","2024-01-30T04:06:19.193+00:00",[],{"title":1469},{"VI":1470},"Service de gynécologie obstétrique, médecine de la reproduction, Hôpitaux universitaires Est Parisien, site Tenon, 4, rue de la Chine, 75020 Paris, France",{"id":1472,"sortIndex":115,"affiliation":1473,"properties":1481},"7b5fc26c-6e71-4c7d-8b0e-1616666f17d6",{"id":1474,"createTime":1475,"updateTime":1475,"relativeEntities":1476,"slug":1477,"properties":1478,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"4e1354ba-6c4d-4094-9070-97ff57c2e0ff","2023-11-26T19:38:23.258+00:00",[],"Universit%C3%A9-Pierre-et-Marie-Curie-Paris-6-4-place-Jussieu-75005-Paris-France",{"title":1479},{"VI":1480},"Université Pierre-et-Marie-Curie Paris-6, 4, place Jussieu, 75005 Paris, France",{},{"title":1483},{"VI":1175},{"id":1485,"sortIndex":114,"researcher":26,"roles":1486,"affiliations":1487,"properties":1496},"7350d3a6-ec23-4dce-ba09-d16261a6fd38",[696],[1488],{"id":26,"sortIndex":36,"affiliation":1489,"properties":26},{"id":1490,"createTime":1491,"updateTime":1491,"relativeEntities":1492,"slug":26,"properties":1493,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d64e29dd-592d-4e21-8a17-5adfb60dc9f9","2024-01-30T04:06:19.207+00:00",[],{"title":1494},{"VI":1495},"Service d’endocrinologie, Hôpitaux universitaires Est Parisien, site Saint-Antoine, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France",{"title":1497},{"VI":1498},"S. Ouzounian",{"id":1500,"sortIndex":59,"researcher":26,"roles":1501,"affiliations":1502,"properties":1508},"f4ad2858-6c6b-43ca-ab0c-ccb944b6fc24",[696],[1503],{"id":26,"sortIndex":36,"affiliation":1504,"properties":26},{"id":1465,"createTime":1466,"updateTime":1466,"relativeEntities":1505,"slug":26,"properties":1506,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1507},{"VI":1470},{"title":1509},{"VI":1510},"E. Darai",{"id":1512,"sortIndex":115,"researcher":26,"roles":1513,"affiliations":1514,"properties":1520},"6675fcc0-bdb1-43c1-8204-950a373d77e7",[696],[1515],{"id":26,"sortIndex":36,"affiliation":1516,"properties":26},{"id":1465,"createTime":1466,"updateTime":1466,"relativeEntities":1517,"slug":26,"properties":1518,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1519},{"VI":1470},{"title":1521},{"VI":1522},"A. Thomin",{"url":1457,"publisher":1524,"properties":1532},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1525,"slug":662,"properties":1526,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1529,"manageAffiliations":1530,"indexDatabases":1531,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1527,"title":1528},{"VOID":665},{"EN":667},[],[],[],{"volume":1533,"pages":1535},{"VOID":1534},"52",{"VOID":962},"2016-09-01",2016,{"id":1539,"createTime":1540,"updateTime":1541,"relativeEntities":1542,"slug":1543,"properties":1544,"entityType":688,"verifyStatus":25,"verifyTime":1541,"verifyNote":690,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":1551,"fullTextUrl":26,"authors":1552,"publicationType":747,"publisherRelationship":1568,"citationCount":26,"citationInfo":26,"publishDate":1582,"publishYear":1583,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":26,"isForceReanalyzing":772},"b3624944-c1a4-429b-a530-690e374dcc3a","2024-01-15T16:31:33.208+00:00","2025-01-31T02:04:22.989+00:00",[],"Esp%C3%A1tulas-de-Thierry",{"references":1545,"title":1547,"doi":1549},{"VOID":1546},"Fournié, 1990, Les applications de spatules de Thierry au CHU de Toulouse en1988, Rev Fr Gynécol Obstét, 85, 553\nFournié A, Parant O. Technique d'application des spatules de Thierry. In : Techniques Chirurgicales et obstétricales, Collège National des Gynécologues et Obstétriciens Français. Cassette VIII, 1999\nNahmanovici, 1981, Techniques d'extraction du fœtus par spatules\nThierry, 1978",{"ES":1548},"Espátulas de Thierry",{"VOID":1550},"10.1016\u002Fs1283-081x(04)70222-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1283081X04702222",[1553],{"id":1554,"sortIndex":36,"researcher":26,"roles":1555,"affiliations":1556,"properties":1565},"6ff2d94e-b15f-4682-a076-86610c1da05d",[696],[1557],{"id":26,"sortIndex":36,"affiliation":1558,"properties":26},{"id":1559,"createTime":1560,"updateTime":1560,"relativeEntities":1561,"slug":26,"properties":1562,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"ed79d5e7-a877-4270-bca7-98804acf522a","2024-01-15T16:31:33.236+00:00",[],{"title":1563},{"VI":1564},"Service de gynécologie-obstétrique, centre hospitalier universitaire de Caen, 49033 Angers, France",{"title":1566},{"VI":1567},"Alain Fournié",{"url":1551,"publisher":1569,"properties":1577},{"id":659,"createTime":660,"updateTime":660,"relativeEntities":1570,"slug":662,"properties":1571,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1574,"manageAffiliations":1575,"indexDatabases":1576,"url":26,"thumbnailPath":26,"statistic":26,"gsStatistic":26,"type":26,"analyzePriority":26},[],{"issn":1572,"title":1573},{"VOID":665},{"EN":667},[],[],[],{"volume":1578,"pages":1580},{"VOID":1579},"40",{"VOID":1581},"1-5","2004-01-01",2004]